,Compound_ID,Uniprot_ID,Compound_Name,Standard_inchi_key,Max_Phase,Target_Pref_Name,Gene_Names,Target_Class,Wild_type_or_mutant,Mutation_information,PubMed_ID,End_Point_Standard_Type,End_Point_Standard_Relation,End_Point_Standard_Value,End_Point_Standard_Units,Endpoint_Mode_of_Action,Assay_Format,Assay_Type,Assay_Sub_Type,Inhibitor_Type,Detection_Technology,Compound_concentration_value,Compound_concentration_value_units,Substrate_type,Substrate_Type_Standard_Relation,Substrate_Type_Standard_Value,Substrate_Type_Standard_Units,Assay_cell_line,Assay_Description,Activity_Comments,Title,Journal,Year,Volume,Issue,Authors,Annotation_Comments,Assay_ID,DTC_Tid,DTC_Activity_ID,DTC_Molregno,Record_ID,DTC_Document_ID,pDTC_Value,SMILES,base_rdkit_smiles
39,CHEMBL104700,P23975,,SCDKHPSUXHBJDJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478144,DTCC00272114,931177,48255,50.0,C1CC2CCC1N2CC3=CN=CC=C3,c1cncc(CN2C3CCC2CC3)c1
137,CHEMBL1079079,P23975,,WGIPGQAPFNVWIX-XXFZXMJFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19767206.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM by scintillation counting,,Synthesis and in vitro autoradiographic evaluation of a novel high-affinity radioiodinated ligand for imaging brain cannabinoid subtype-1 receptors.,Bioorg. Med. Chem. Lett.,2009.0,19.0,21.0,"Donohue SR, Varnäs K, Jia Z, Gulyás B, Pike VW, Halldin C",,619820.0,DTCT0023180,3267827,DTCC00632772,857661,37697,50.0,COC1=CC=C(C=C1)C2=C(C(=NN2C3=CC=CC=C3[125I])C(=O)NN4CCCCC4)C#N,COc1ccc(-c2c(C#N)c(C(=O)NN3CCCCC3)nn2-c2ccccc2I)cc1
143,CHEMBL108,P23975,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7262068,DTCC00144764,249939,46191,,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,NC(=O)N1c2ccccc2C=Cc2ccccc21
144,CHEMBL108,P23975,CARBAMAZEPINE,FFGPTBGBLSHEPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7262069,DTCC00144764,249939,46191,,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,NC(=O)N1c2ccccc2C=Cc2ccccc21
180,CHEMBL1082723,P23975,NITD609,CKLPLPZSUQEDRT-WPCRTTGESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20813948.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant norepinephrine transporter,,"Spiroindolones, a potent compound class for the treatment of malaria.",Science,2010.0,329.0,5996.0,"Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, González-Páez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT",,658576.0,DTCT0023180,3467853,DTCC00031143,1686650,40818,10000.0,C[C@H]1CC2=C([C@]3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,C[C@H]1Cc2c([nH]c3cc(Cl)c(F)cc23)[C@@]2(N1)C(=O)Nc1ccc(Cl)cc12
336,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,20.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755650,DTCC00132703,2110616,68466,20.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
337,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,142.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755649,DTCC00132703,2110616,68466,142.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
338,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,37.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755651,DTCC00132703,2110742,68566,37.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
339,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589.0,KI,=,118.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755648,DTCC00132703,2110619,69057,118.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
340,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845.0,KI,=,98.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14755652,DTCC00132703,2110743,68736,98.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
341,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,15081025.0,KI,=,16.0,NM,,,,,,,,,,,,,,Binding affinity towards Norepinephrine transporter using [3H]nisoxitine as radioligand,,"Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA).",Bioorg. Med. Chem. Lett.,2004.0,14.0,9.0,"Peddi S, Roth BL, Glennon RA, Westkaemper RB",,143139.0,DTCT0023180,840658,DTCC00132703,3614,6858,16.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
342,CHEMBL11,P23975,IMIPRAMINE,BCGWQEUPMDMJNV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138.0,IC50,=,74.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007.0,51.0,11.0,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923.0,DTCT0023180,2718430,DTCC00132703,9998,34126,74.0,CN(C)CCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CN(C)CCCN1c2ccccc2CCc2ccccc21
353,CHEMBL1110,P23975,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7287265,DTCC00258915,1318437,46191,,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O
354,CHEMBL1110,P23975,ALOSETRON,JSWZEAMFRNKZNL-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7287266,DTCC00258915,1318437,46191,,CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C,Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O
357,CHEMBL1112,P23975,ARIPIPRAZOLE,CEUORZQYGODEFX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12784105.0,KI,=,2090.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14756448,DTCC00106550,2110875,69826,2090.0,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
361,CHEMBL111639,P23975,FLUOROCARAZOLOL,QHLGXPUIUKSADT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11512051.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736651,DTCC00281815,2106040,69642,10000.0,CC(CF)NCC(COC1=CC=CC2=C1C3=CC=CC=C3N2)O,CC(CF)NCC(O)COc1cccc2[nH]c3ccccc3c12
447,CHEMBL1171434,P23975,,XVOYSCVBGLVSOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14737613,DTCC00655109,2106368,69159,10000.0,C(C(C(=O)O)N)S(=O)(=O)O,NC(CS(=O)(=O)O)C(=O)O
561,CHEMBL1189234,P23975,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11474386,DTCC00667938,1780157,51935,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccc1
562,CHEMBL1189234,P23975,,YSEXVIPNIGQQMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12600279,DTCC00667938,1780916,55935,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccc1
714,CHEMBL1224034,P23975,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20692833.0,INHIBITION,=,34.1,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET at 10 uM,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010.0,20.0,18.0,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652469.0,DTCT0023180,3449434,DTCC00692765,716520,40427,34.1,C1CCC(CC1)NC(=O)N2C3C(CO2)CSC4=C3C=C(C=C4)F,O=C(NC1CCCCC1)N1OCC2CSc3ccc(F)cc3C21
715,CHEMBL1224034,P23975,,WPNGDOZEXVRNMZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20692833.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET,,N-tetrahydrothiochromenoisoxazole-1-carboxamides as selective antagonists of cloned human 5-HT2B.,Bioorg. Med. Chem. Lett.,2010.0,20.0,18.0,"Kwon YJ, Saubern S, Macdonald JM, Huang XP, Setola V, Roth BL",,652474.0,DTCT0023180,3449439,DTCC00692765,716520,40427,10000.0,C1CCC(CC1)NC(=O)N2C3C(CO2)CSC4=C3C=C(C=C4)F,O=C(NC1CCCCC1)N1OCC2CSc3ccc(F)cc3C21
819,CHEMBL1241348,P23975,FALDAPREVIR,LLGDPTDZOVKFDU-XUHJSTDZSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20823284.0,INHIBITION,=,20.0,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,2010.0,54.0,11.0,"White PW, Llinàs-Brunet M, Amad M, Bethell RC, Bolger G, Cordingley MG, Duan J, Garneau M, Lagacé L, Thibeault D, Kukolj G",,724378.0,DTCT0023180,5127096,DTCC00126282,118904,43507,20.0,CC(C)C(=O)NC1=NC(=CS1)C2=NC3=C(C=CC(=C3Br)OC)C(=C2)O[C@@H]4C[C@H](N(C4)C(=O)[C@H](C(C)(C)C)NC(=O)OC5CCCC5)C(=O)N[C@@]6(C[C@H]6C=C)C(=O)O,C=C[C@@H]1C[C@]1(NC(=O)[C@@H]1C[C@@H](Oc2cc(-c3csc(NC(=O)C(C)C)n3)nc3c(Br)c(OC)ccc23)CN1C(=O)[C@@H](NC(=O)OC1CCCC1)C(C)(C)C)C(=O)O
822,CHEMBL1242923,P23975,,FLGSUSWMWSZVMP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20684563.0,KI,>=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to human NE transporter by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659601.0,DTCT0023180,3460938,DTCC00697046,1200707,40772,1000.0,C1CN(CCC1NC(=O)CC2=CC=CC=C2)CCCN3C(=O)COC4=CC=CC=C43,O=C(Cc1ccccc1)NC1CCN(CCCN2C(=O)COc3ccccc32)CC1
823,CHEMBL1242950,P23975,AC-42,ANTKBACNWQHQJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20684563.0,KI,>=,1000.0,NM,,,,,,,,,,,,,,Binding affinity to human NE transporter by radioligand displacement assay,,"Discovery of N-{1-[3-(3-Oxo-2,3-dihydrobenzo[1,4]oxazin-4-yl)propyl]piperidin-4-yl}-2-phenylacetamide (Lu AE51090): an allosteric muscarinic M1 receptor agonist with unprecedented selectivity and procognitive potential.",J. Med. Chem.,2010.0,53.0,17.0,"Sams AG, Hentzer M, Mikkelsen GK, Larsen K, Bundgaard C, Plath N, Christoffersen CT, Bang-Andersen B",,659601.0,DTCT0023180,3460939,DTCC00032233,1972874,40772,1000.0,CCCCC1CCN(CC1)CCCC(=O)C2=CC=CC=C2C,CCCCC1CCN(CCCC(=O)c2ccccc2C)CC1
836,CHEMBL1258223,P23975,,WKWADEWWLCVVLF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20812727.0,KI,=,3226.0,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664967.0,DTCT0023180,3532980,DTCC00701398,1168405,41144,3226.0,CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)NC)Cl,CCCCN1CCC(COC(=O)c2cc(Cl)c(NC)c3c2OCCO3)CC1
837,CHEMBL1258452,P23975,,DZZIAERGLDKTBT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20812727.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664967.0,DTCT0023180,3533024,DTCC00701623,716604,41144,10000.0,CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C=C2)N)OC,CCCCN1CCC(COC(=O)c2ccc(N)c(OC)c2)CC1
838,CHEMBL1258614,P23975,,IUEKKZWRWOFGRT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of norepinephrine receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664309.0,DTCT0023180,3527801,DTCC00701782,911256,41064,50.0,CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OCC)C)C,CCOc1ccc(-c2nn3c(C)cc(C)nc3c2CC(=O)N(CC)CC)cc1
839,CHEMBL1258671,P23975,,WLHFUBIRAHRPHA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20812727.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis, structure--affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.",J. Med. Chem.,2010.0,53.0,19.0,"Xu R, Hong J, Morse CL, Pike VW",,664967.0,DTCT0023180,3533068,DTCC00701836,911257,41144,10000.0,CCCCN1CCC(CC1)COC(=O)C2=CC(=C(C3=C2OCCO3)N)F,CCCCN1CCC(COC(=O)c2cc(F)c(N)c3c2OCCO3)CC1
842,CHEMBL1258843,P23975,,VHENJOBTWCOIPN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20727749.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of norepinephrine receptor at 10 uM,,"Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).",Bioorg. Med. Chem. Lett.,2010.0,20.0,19.0,"Reynolds A, Hanani R, Hibbs D, Damont A, Da Pozzo E, Selleri S, Dollé F, Martini C, Kassiou M",,664309.0,DTCT0023180,3527904,DTCC00702004,1265966,41064,50.0,CCN(CC)C(=O)CC1=C2N=C(C=C(N2N=C1C3=CC=C(C=C3)OCC#C)C)C,C#CCOc1ccc(-c2nn3c(C)cc(C)nc3c2CC(=O)N(CC)CC)cc1
856,CHEMBL1278088,P23975,,WFQOETMVYMINSA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20931963.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET,,"Discovery of a novel 5-HT(3) antagonist/5-HT(1A) agonist 3-amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3H)-one (TZB-30878) as an orally bioavailable agent for irritable bowel syndrome.",J. Med. Chem.,2010.0,53.0,21.0,"Asagarasu A, Matsui T, Hayashi H, Tamaoki S, Yamauchi Y, Minato K, Sato M",,684929.0,DTCT0023180,3586989,DTCC00707742,716661,41871,1000.0,C1CCC2=C(C1)C(=O)N(C(=N2)CCCCN3CCN(CC3)C4=NC5=CC=CC=C5C=C4)N,Nn1c(CCCCN2CCN(c3ccc4ccccc4n3)CC2)nc2c(c1=O)CCCC2
857,CHEMBL128,P23975,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7478550,DTCC00154636,671796,46191,,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1
858,CHEMBL128,P23975,SUMATRIPTAN,KQKPFRSPSRPDEB-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7478551,DTCC00154636,671796,46191,,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1
916,CHEMBL133455,P23975,,VVHJUSGIUWQPIT-VIFPVBQESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954071.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibitory constant against norepinephrine transporter receptor using [3H]radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003.0,46.0,19.0,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,144998.0,DTCT0023180,1106914,DTCC00315452,2045939,17506,10000.0,C[C@@H](CC1=CNC2=C1C3=C(C=C2)OCCC3)N,C[C@H](N)Cc1c[nH]c2ccc3c(c12)CCCO3
920,CHEMBL133868,P23975,,VVHJUSGIUWQPIT-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12954071.0,KI,>,30000.0,NM,,,,,,,,,,,,,,Inhibitory constant against norepinephrine transporter receptor using [3H]radioligand,,"A novel and selective 5-HT2 receptor agonist with ocular hypotensive activity: (S)-(+)-1-(2-aminopropyl)-8,9-dihydropyrano[3,2-e]indole.",J. Med. Chem.,2003.0,46.0,19.0,"May JA, Chen HH, Rusinko A, Lynch VM, Sharif NA, McLaughlin MA",,144998.0,DTCT0023180,1109521,DTCC00315451,173712,17506,30000.0,CC(CC1=CNC2=C1C3=C(C=C2)OCCC3)N,CC(N)Cc1c[nH]c2ccc3c(c12)CCCO3
1051,CHEMBL14376,P23975,ILOPERIDONE,XMXHEBAFVSFQEX-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11750183.0,KI,=,1479.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732031,DTCC00143788,2104585,69484,1479.0,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,COc1cc(C(C)=O)ccc1OCCCN1CCC(c2noc3cc(F)ccc23)CC1
1121,CHEMBL148489,P23975,N-(3-PYRIDYLMETHYL)PYRROLIDINE,YFCWBKBNFCDPDF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478858,DTCC00339052,2026783,48255,50.0,C1CCN(C1)CC2=CN=CC=C2,c1cncc(CN2CCCC2)c1
1156,CHEMBL1516176,P23975,,PDNJLMZEGXHSCU-VKHMYHEASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14742313,DTCC00912618,2108018,69159,10000.0,C(CS(=O)O)[C@@H](C(=O)O)N,N[C@@H](CCS(=O)O)C(=O)O
1262,CHEMBL1614664,P23975,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14759178,DTCC01003548,2107269,69275,10000.0,CC1=CC(=C2C3=C4C5=C(C(=O)C=C(C5=C2O)O)C6=C7C4=C8C(=C13)C(=CC(=C8C(=C7C(=CC6=O)O)O)O)CO)O,Cc1cc(O)c2c(O)c3c(O)cc(=O)c4c5c(=O)cc(O)c6c(O)c7c(O)cc(CO)c8c1c2c(c34)c(c78)c65
1263,CHEMBL1614664,P23975,PSEUDOHYPERICIN,YXBUQQDFTYOHQI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14759827,DTCC01003548,2107269,69275,10000.0,CC1=CC(=C2C3=C4C5=C(C(=O)C=C(C5=C2O)O)C6=C7C4=C8C(=C13)C(=CC(=C8C(=C7C(=CC6=O)O)O)O)CO)O,Cc1cc(O)c2c(O)c3c(O)cc(=O)c4c5c(=O)cc(O)c6c(O)c7c(O)cc(CO)c8c1c2c(c34)c(c78)c65
1330,CHEMBL1643899,P23975,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989.0,KI,=,5883.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847.0,DTCT0023180,5036589,DTCC01020576,166198,42620,5883.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC(=CC=C6)F,Fc1cccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)c1
1331,CHEMBL1643899,P23975,,JDFBBZLNLYXHDC-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,=,5883.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12601185,DTCC01020576,168448,55935,5883.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC(=CC=C6)F,Fc1cccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)c1
1332,CHEMBL1643900,P23975,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989.0,KI,=,3623.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847.0,DTCT0023180,5036585,DTCC01020577,942929,42620,3623.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC(=CC=C6)F,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
1333,CHEMBL1643900,P23975,,FZIIBLBHXXRTMG-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,=,3623.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12601189,DTCC01020577,945255,55935,3623.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC(=CC=C6)F,Fc1cccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)c1
1334,CHEMBL1643901,P23975,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847.0,DTCT0023180,5036568,DTCC01020578,1460729,42620,50.0,CN(CC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
1335,CHEMBL1643901,P23975,,GACBJAOXQGFNDL-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601148,DTCC01020578,1463030,55935,50.0,CN(CC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
1336,CHEMBL1643902,P23975,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21146989.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in HEK cells,,Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,1.0,"Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M",,700847.0,DTCT0023180,5036570,DTCC01020579,619871,42620,50.0,CN(CCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
1337,CHEMBL1643902,P23975,,LGZPNSXZRKGUES-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601144,DTCC01020579,622243,55935,50.0,CN(CCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
1397,CHEMBL1651208,P23975,,DWTYHCYVKJONSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23009245.0,INHIBITION,=,4.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human NET at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012.0,55.0,22.0,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876170.0,DTCT0023180,11437727,DTCC01023515,317585,51586,4.0,C1CCC(C1)N2CC3=C(C2=O)C=CC(=C3)OCC4=CC(=CC=C4)C5=CC(=C(C=C5)Cl)C(=O)O,O=C(O)c1cc(-c2cccc(COc3ccc4c(c3)CN(C3CCCC3)C4=O)c2)ccc1Cl
1398,CHEMBL1651219,P23975,,ZQBPXBADOJMCRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23009245.0,INHIBITION,=,-17.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human NET at 10 uM,,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,2012.0,55.0,22.0,"Sidique S, Dhanya RP, Sheffler DJ, Nickols HH, Yang L, Dahl R, Mangravita-Novo A, Smith LH, D'Souza MS, Semenova S, Conn PJ, Markou A, Cosford ND",,876170.0,DTCT0023180,11437678,DTCC01023526,1675972,51586,-17.0,C1CCC(C1)N2C(=O)C3=C(S2)C=C(C=C3)OCC4=CC(=CC=C4)C5=CC(=C(C=C5)Cl)C(=O)O,O=C(O)c1cc(-c2cccc(COc3ccc4c(=O)n(C5CCCC5)sc4c3)c2)ccc1Cl
1405,CHEMBL1668584,P23975,,YPVOSIDECMYMTD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21333408.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to norepinephrine transporter at 10 uM by radioligand binding assay,Not Active,"2-Substituted 5,6-dimethyl-3-phenylsulfonyl-pyrazolo[1,5-a]pyrimidines: new series of highly potent and specific serotonin 5-HT6 receptor antagonists.",Eur. J. Med. Chem.,2011.0,46.0,4.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Koryakova AG, Mitkin OD, Tkachenko SE, Kysil VM, Okun I",,740381.0,DTCT0023180,5907297,DTCC01025412,943137,44130,,CC1=CC(=NC2=C(C(=NN12)NC)S(=O)(=O)C3=CC=CC=C3)C,CNc1nn2c(C)cc(C)nc2c1S(=O)(=O)c1ccccc1
1406,CHEMBL1669669,P23975,RO-5212773,KLFVWQCQUXXLOU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21237643.0,INHIBITION,=,44.0,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Selective antagonists of mouse trace amine-associated receptor 1 (mTAAR1): discovery of EPPTB (RO5212773).,Bioorg. Med. Chem. Lett.,2011.0,21.0,4.0,"Stalder H, Hoener MC, Norcross RD",,716528.0,DTCT0023180,5105760,DTCC00033580,1557659,43309,44.0,CCOC1=CC=CC(=C1)NC(=O)C2=CC(=C(C=C2)N3CCCC3)C(F)(F)F,CCOc1cccc(NC(=O)c2ccc(N3CCCC3)c(C(F)(F)F)c2)c1
1409,CHEMBL1672288,P23975,,LVXAMCKZCLWWTF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21207959.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to NET,,Syntheses of 2-amino and 2-halothiazole derivatives as high-affinity metabotropic glutamate receptor subtype 5 ligands and potential radioligands for in vivo imaging.,J. Med. Chem.,2011.0,54.0,3.0,"Siméon FG, Wendahl MT, Pike VW",,718176.0,DTCT0023180,5116597,DTCC01026954,798550,43561,10000.0,C1=C(C=C(C=C1C#N)F)C#CC2=CSC(=N2)F,N#Cc1cc(F)cc(C#Cc2csc(F)n2)c1
1485,CHEMBL1702607,P23975,,ADVPTQAUNPRNPO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733105,DTCC01037443,2104825,69159,10000.0,C(C(C(=O)O)N)S(=O)O,NC(CS(=O)O)C(=O)O
1508,CHEMBL1738699,P23975,,YVPGZQLRPAGKLA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219.0,DTCT0023180,5976447,DTCC01070772,735160,44781,50.0,CC1=C(C=CC(=C1)C(=O)N)N2C(=CC=C2C3=CC=C(C=C3)N4C=CN=C4)CCC(=O)O,Cc1cc(C(N)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1
1554,CHEMBL1765683,P23975,,ZVRXOXFSMYJETP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21428406.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011.0,54.0,8.0,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743847.0,DTCT0023180,5918995,DTCC01078226,652599,44302,50.0,CC1=C(N(N=C1C(=O)NC2(CCOCC2)C#N)C3=CC=CC=C3Br)C4=CC=C(C=C4)OC,COc1ccc(-c2c(C)c(C(=O)NC3(C#N)CCOCC3)nn2-c2ccccc2Br)cc1
1555,CHEMBL1765684,P23975,,VCKIDQVWSDVZCZ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21428406.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM by radioligand binding assay,,"N-(4-Cyanotetrahydro-2H-pyran-4-yl) and N-(1-Cyanocyclohexyl) Derivatives of 1,5-Diarylpyrazole-3-carboxamides Showing High Affinity for 18 kDa Translocator Protein and/or Cannabinoid Receptors.",J. Med. Chem.,2011.0,54.0,8.0,"Donohue SR, Dannals RF, Halldin C, Pike VW",,743847.0,DTCT0023180,5918996,DTCC01078227,975211,44302,50.0,CC1=C(N(N=C1C(=O)NC2(CCCCC2)C#N)C3=CC=CC=C3Br)C4=CC=C(C=C4)OC,COc1ccc(-c2c(C)c(C(=O)NC3(C#N)CCCCC3)nn2-c2ccccc2Br)cc1
1569,CHEMBL1783889,P23975,,DSNALXIKDKGHLJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496655.0,DTCT0023180,14434955,DTCC01087435,1615288,62611,,CC(C)N1CCN(CC1)C(=O)C2=CC=C(C=C2)CN3CCCCC3,CC(C)N1CCN(C(=O)c2ccc(CN3CCCCC3)cc2)CC1
1570,CHEMBL1784671,P23975,,NVCJMYLJSSPEKR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219.0,DTCT0023180,5976448,DTCC01088207,184448,44781,50.0,CC1=C(C=CC(=C1)C(=O)N)C2=C(C=CN2C3=CC=C(C=C3)N4C=CN=C4)CCC(=O)O,Cc1cc(C(N)=O)ccc1-c1c(CCC(=O)O)ccn1-c1ccc(-n2ccnc2)cc1
1571,CHEMBL1784673,P23975,,CPOQTXKWWFQYCF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Not Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219.0,DTCT0023180,5976449,DTCC01088209,314586,44781,50.0,CC1=C(C=CC(=C1)C(=O)N)C2=C(C=CN2CCC(=O)O)C3=CC=C(C=C3)N4C=CN=C4,Cc1cc(C(N)=O)ccc1-c1c(-c2ccc(-n3ccnc3)cc2)ccn1CCC(=O)O
1572,CHEMBL1784685,P23975,,APARPRRWRUIPGQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219.0,DTCT0023180,5976450,DTCC01088221,1764905,44781,50.0,CC1=C(C=CC(=C1)C(=O)N)C2=C(C=CN2C3=CC(=C(C=C3)C(=O)O)O)C4=CC=C(C=C4)OC,COc1ccc(-c2ccn(-c3ccc(C(=O)O)c(O)c3)c2-c2ccc(C(N)=O)cc2C)cc1
1573,CHEMBL1784694,P23975,,USRJTKDRTOTPRU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21570838.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human recombinant NET at 10 uM by radioligand binding assay,Active,Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.,Bioorg. Med. Chem. Lett.,2011.0,21.0,12.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Colagiovanni DB, Mutka SC, Blonder JP, Stout AM, Richards JP, Chun L, Rosenthal GJ",,751219.0,DTCT0023180,5976451,DTCC01088230,347293,44781,50.0,CC1=C(C=CC(=C1)C(=O)N)C2=C(C=CN2C3=CC(=C(C=C3)O)[N+](=O)[O-])C4=CC=C(C=C4)OC,COc1ccc(-c2ccn(-c3ccc(O)c([N+](=O)[O-])c3)c2-c2ccc(C(N)=O)cc2C)cc1
1585,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918.0,KI,=,15.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736025,DTCC00383453,2105849,69315,15.8,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1586,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845.0,KI,=,11.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14736026,DTCC00383453,2105848,68736,11.0,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1587,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18672364.0,IC50,=,3.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET expressed in HEK293 cells,,Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.,Bioorg. Med. Chem. Lett.,2008.0,18.0,16.0,"Hudson S, Kiankarimi M, Eccles W, Dwight W, Mostofi YS, Genicot MJ, Fleck BA, Gogas K, Aparicio A, Wang H, Wen J, Wade WS",,510091.0,DTCT0023180,2447044,DTCC00383453,1362808,30886,3.0,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1588,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19067522.0,KI,=,1.04,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]nisoxetine from human NET receptor expressed in HEK293 cells,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and fluorine-18 labeled reboxetine analogues: potential positron emission tomography radioligands for in vivo imaging of the norepinephrine transporter.",J. Med. Chem.,2009.0,52.0,1.0,"Zeng F, Mun J, Jarkas N, Stehouwer JS, Voll RJ, Tamagnan GD, Howell L, Votaw JR, Kilts CD, Nemeroff CB, Goodman MM",,560274.0,DTCT0023180,2450472,DTCC00383453,1362421,31766,1.04,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1589,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525.0,IC50,=,3.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009.0,52.0,18.0,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225.0,DTCT0023180,2901947,DTCC00383453,1374683,35305,3.1,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1590,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247.0,KI,=,0.3,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009.0,17.0,22.0,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447.0,DTCT0023180,3155569,DTCC00383453,669727,36729,0.3,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1591,CHEMBL180101,P23975,ESREBOXETINE,CBQGYUDMJHNJBX-OALUTQOASA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23347683.0,IC50,=,2.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of human recombinant NET expressed in HEK293 cells assessed as inhibition of [3H]NE reuptake,,A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.,Bioorg. Med. Chem. Lett.,2013.0,23.0,5.0,"Van Orden LJ, Van Dyke PM, Saito DR, Church TJ, Chang R, Smith JA, Martin WJ, Jaw-Tsai S, Stangeland EL",,943623.0,DTCT0023180,11800437,DTCC00383453,1366045,53876,2.0,CCOC1=CC=CC=C1O[C@H]([C@@H]2CNCCO2)C3=CC=CC=C3,CCOc1ccccc1O[C@@H](c1ccccc1)[C@@H]1CNCCO1
1605,CHEMBL1812545,P23975,,JDBSZVDIUIRSDG-DAFODLJHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21726069.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NE transporter at 10 uM relative to control,,"Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.",J. Med. Chem.,2011.0,54.0,15.0,"Dolusic E, Larrieu P, Moineaux L, Stroobant V, Pilotte L, Colau D, Pochet L, Van den Eynde B, Masereel B, Wouters J, Frédérick R",,762045.0,DTCT0023180,6053739,DTCC01099864,1959018,45491,10.0,C1=CC2=C(C=C1F)NC=C2/C=C/C3=NNN=N3,Fc1ccc2c(/C=C/c3nn[nH]n3)c[nH]c2c1
1701,CHEMBL1824777,P23975,,ZHHLHBNBIKLLJG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET transporter at 10 uM by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767217.0,DTCT0023180,6091822,DTCC01106515,961498,45468,50.0,C1C2CC3CC1CC(C2)(N3CC4=CC=CC=C4)O.Cl,OC12CC3CC(CC(C3)N1Cc1ccccc1)C2
1702,CHEMBL1824778,P23975,,LPAMOYXJLQSGRI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of NET transporter by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767228.0,DTCT0023180,6074480,DTCC01106516,1058448,45468,10000.0,C1C2CC3CC1CC(C2)(N3CC4=CC(=CC=C4)F)O.Cl,OC12CC3CC(CC(C3)N1Cc1cccc(F)c1)C2
1703,CHEMBL1824784,P23975,,HXOMGUPFBWZKBK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of NET transporter by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767228.0,DTCT0023180,6074481,DTCC01106522,638709,45468,10000.0,C1C2CC3CC1CC(C2)N3CC4=CC=CC=C4.Cl,c1ccc(CN2C3CC4CC(C3)CC2C4)cc1
1704,CHEMBL1824785,P23975,,ZILQWXOKQUVSTI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21788137.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of NET transporter by NIMH PDSP,,N-Arylalkyl-2-azaadamantanes as cage-expanded polycarbocyclic sigma (s) receptor ligands.,Bioorg. Med. Chem. Lett.,2011.0,21.0,18.0,"Banister SD, Yoo DT, Chua SW, Cui J, Mach RH, Kassiou M",,767228.0,DTCT0023180,6074482,DTCC01106523,1640941,45468,10000.0,C1C2CC3CC1CC(C2)N3CC4=CC(=CC=C4)F.Cl,Fc1cccc(CN2C3CC4CC(C3)CC2C4)c1
1707,CHEMBL1829335,P23975,IRDABISANT,XUKROCVZGZNGSI-CQSZACIVSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21634396.0,IC50,=,17500.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human norepinephrine transporter,,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,2011.0,54.0,13.0,"Hudkins RL, Raddatz R, Tao M, Mathiasen JR, Aimone LD, Becknell NC, Prouty CP, Knutsen LJ, Yazdanian M, Moachon G, Ator MA, Mallamo JP, Marino MJ, Bacon ER, Williams M",,761643.0,DTCT0023180,6055967,DTCC01107613,1558037,45444,17500.0,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)C3=NNC(=O)C=C3,C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1
1708,CHEMBL1829335,P23975,IRDABISANT,XUKROCVZGZNGSI-CQSZACIVSA-N,1,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21634396.0,KI,=,10000.0,NM,,,,,,,,,,,,,,Inhibition of norepinephrine transporter ,,"Discovery and characterization of 6-{4-[3-(R)-2-methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, irdabisant): a potent, selective histamine H3 receptor inverse agonist.",J. Med. Chem.,2011.0,54.0,13.0,"Hudkins RL, Raddatz R, Tao M, Mathiasen JR, Aimone LD, Becknell NC, Prouty CP, Knutsen LJ, Yazdanian M, Moachon G, Ator MA, Mallamo JP, Marino MJ, Bacon ER, Williams M",,761553.0,DTCT0023180,6055963,DTCC01107613,1558037,45444,10000.0,C[C@@H]1CCCN1CCCOC2=CC=C(C=C2)C3=NNC(=O)C=C3,C[C@@H]1CCCN1CCCOc1ccc(-c2ccc(=O)[nH]n2)cc1
1757,CHEMBL184238,P23975,URB597,ROFVXGGUISEHAM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16352709.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740664,DTCC00000860,2107472,69711,10000.0,C1CCC(CC1)NC(=O)OC2=CC=CC(=C2)C3=CC(=CC=C3)C(=O)N,NC(=O)c1cccc(-c2cccc(OC(=O)NC3CCCCC3)c2)c1
1772,CHEMBL1885748,P23975,,JQSJAVBMIMDUFO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23642479.0,INHIBITION,=,59.0,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM relative to control,,Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315.,Bioorg. Med. Chem. Lett.,2013.0,23.0,12.0,"Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J",,965549.0,DTCT0023180,12471419,DTCC01135294,545285,54833,59.0,C1OC2=C(O1)C=C(C=C2)C3=CN=CN=C3NCC4=CC(=CC(=C4)Cl)Cl,Clc1cc(Cl)cc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1
1865,CHEMBL19215,P23975,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20451398.0,ACTIVITY,=,1132.0,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human cloned NET,,Evaluation of [(11)C]metergoline as a PET radiotracer for 5HTR in nonhuman primates.,Bioorg. Med. Chem.,2010.0,18.0,22.0,"Hooker JM, Kim SW, Reibel AT, Alexoff D, Xu Y, Shea C",,681154.0,DTCT0023180,3578670,DTCC00150357,296043,41784,1132.0,CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
1866,CHEMBL19215,P23975,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,366.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7415123,DTCC00150357,315666,46191,366.0,CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
1867,CHEMBL19215,P23975,METERGOLINE,WZHJKEUHNJHDLS-QTGUNEKASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,363.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7415124,DTCC00150357,315666,46191,363.0,CN1C[C@@H](C[C@H]2[C@H]1CC3=CN(C4=CC=CC2=C34)C)CNC(=O)OCC5=CC=CC=C5,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
1882,CHEMBL1939222,P23975,,HTSQRRQNKJNSLH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22191331.0,INHIBITION,=,-10.0,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM by radioligand displacement assay,,ADME-guided design and synthesis of aryloxanyl pyrazolone derivatives to block mutant superoxide dismutase 1 (SOD1) cytotoxicity and protein aggregation: potential application for the treatment of amyotrophic lateral sclerosis.,J. Med. Chem.,2012.0,55.0,1.0,"Chen T, Benmohamed R, Kim J, Smith K, Amante D, Morimoto RI, Kirsch DR, Ferrante RJ, Silverman RB",,858363.0,DTCT0023180,11390338,DTCC01170899,931965,51183,-10.0,C1=C(C=C(C=C1Cl)Cl)OCC2=CC(=O)NN2,O=c1cc(COc2cc(Cl)cc(Cl)c2)[nH][nH]1
1898,CHEMBL1949930,P23975,,IKXSPLZKOZXPFB-RQBPZYBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22226656.0,IC50,=,4400.0,NM,,,,,,,,,,,,,,Inhibition of NA transporter,,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,2012.0,22.0,3.0,"Tripathy R, McHugh RJ, Bacon ER, Salvino JM, Morton GC, Aimone LD, Huang Z, Mathiasen JR, DiCamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Qian J, Angeles TS, Connors T, Spais C, Holskin B, Duzic E, Schaffhauser H, Rossé GC",,804675.0,DTCT0023180,7639586,DTCC01175384,653195,47384,4400.0,CC(C)OC1=CC(=CC(=C1)OC)S(=O)(=O)C2=CC3=C(C=C2)[C@@H]4CCNC[C@@H]4O3.Cl,COc1cc(OC(C)C)cc(S(=O)(=O)c2ccc3c(c2)O[C@H]2CNCC[C@@H]32)c1
1899,CHEMBL1949930,P23975,,IKXSPLZKOZXPFB-RQBPZYBGSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22226656.0,INHIBITION,>,50.0,%,,,,,,,,,,,,,,Inhibition of NA transporter at 10 uM,,"Discovery of 7-arylsulfonyl-1,2,3,4, 4a,9a-hexahydro-benzo[4,5]furo[2,3-c]pyridines: identification of a potent and selective 5-HT6 receptor antagonist showing activity in rat social recognition test.",Bioorg. Med. Chem. Lett.,2012.0,22.0,3.0,"Tripathy R, McHugh RJ, Bacon ER, Salvino JM, Morton GC, Aimone LD, Huang Z, Mathiasen JR, DiCamillo A, Huffman MJ, McKenna BA, Kopec K, Lu LD, Qian J, Angeles TS, Connors T, Spais C, Holskin B, Duzic E, Schaffhauser H, Rossé GC",,804669.0,DTCT0023180,7639580,DTCC01175384,653195,47384,50.0,CC(C)OC1=CC(=CC(=C1)OC)S(=O)(=O)C2=CC3=C(C=C2)[C@@H]4CCNC[C@@H]4O3.Cl,COc1cc(OC(C)C)cc(S(=O)(=O)c2ccc3c(c2)O[C@H]2CNCC[C@@H]32)c1
1965,CHEMBL2012728,P23975,,LTQWNQOQFFXHAJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22342142.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine channel at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012.0,22.0,6.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811316.0,DTCT0023180,10427268,DTCC01227134,427664,47711,,CC1=C(C=CC(=C1)NS(=O)(=O)C)N2C(=CC=C2C3=CC=C(S3)N4C=CN=C4C)CCC(=O)O,Cc1cc(NS(C)(=O)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2C)s1
1966,CHEMBL2012737,P23975,,NFEVAAXMHCVVQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22342142.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of norepinephrine channel at 10 uM by radioligand displacement assay,Not Active,Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.,Bioorg. Med. Chem. Lett.,2012.0,22.0,6.0,"Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ",,811316.0,DTCT0023180,10427269,DTCC01227143,620872,47711,,CC1=C(C=CC(=C1)NS(=O)(=O)C)N2C(=CC=C2C3=CC=C(C=C3)N4C=CN=C4)CCC(=O)O,Cc1cc(NS(C)(=O)=O)ccc1-n1c(CCC(=O)O)ccc1-c1ccc(-n2ccnc2)cc1
1988,CHEMBL2024087,P23975,,FQIJPHXWIONJLF-JKOKRWQUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22171543.0,INHIBITION,=,-10.6,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815956.0,DTCT0023180,10457870,DTCC01232472,1365032,48063,-10.6,C1CN[C@@H]1COC2=CN=CC(=C2)[C@H]3C[C@@H]3CCO,OCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
1989,CHEMBL2024089,P23975,,HGSHFGWWOPXUPH-WHOFXGATSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22171543.0,INHIBITION,=,69.6,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815956.0,DTCT0023180,10457871,DTCC01232474,102538,48063,69.6,CNC(=O)OCC[C@H]1C[C@@H]1C2=CC(=CN=C2)OC[C@@H]3CCN3,CNC(=O)OCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
1992,CHEMBL2024094,P23975,,NMIIKXFGCKOYRV-WHOFXGATSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22171543.0,INHIBITION,=,-0.2,%,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from NET at 10 uM,,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,2012.0,55.0,2.0,"Zhang H, Tückmantel W, Eaton JB, Yuen PW, Yu LF, Bajjuri KM, Fedolak A, Wang D, Ghavami A, Caldarone B, Paterson NE, Lowe DA, Brunner D, Lukas RJ, Kozikowski AP",,815956.0,DTCT0023180,10457872,DTCC01232479,1008460,48063,-0.2,COCC[C@H]1C[C@@H]1C2=CC(=CN=C2)OC[C@@H]3CCN3,COCC[C@H]1C[C@@H]1c1cncc(OC[C@@H]2CCN2)c1
2020,CHEMBL2030622,P23975,,ITUMTGGIBOPIJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478008,DTCC01235111,1610661,48255,50.0,C1CC2CCC1N2CC3=CC=CC=C3,c1ccc(CN2C3CCC2CC3)cc1
2021,CHEMBL2030623,P23975,,HJOLMLNXMCFYQQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478050,DTCC01235112,382111,48255,50.0,C1CC2CCC1N2CC3=CC(=CC=C3)F,Fc1cccc(CN2C3CCC2CC3)c1
2022,CHEMBL2030624,P23975,,MFKYGKXYJBKSQN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478097,DTCC01235113,218663,48255,50.0,COC1=C(C=C(C=C1)CN2C3CCC2CC3)OC,COc1ccc(CN2C3CCC2CC3)cc1OC
2023,CHEMBL2030625,P23975,,JVHYCBRRZUMPEJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478187,DTCC01235114,53054,48255,50.0,C1CCC(CC1)CN2C3CCC2CC3,C1CCC(CN2C3CCC2CC3)CC1
2024,CHEMBL2030626,P23975,,TWUZJTIHFYRNSV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478235,DTCC01235115,1735130,48255,50.0,C1CC2CCC1N2CC34C5C6C3C7C6C5C47,C1CC2CCC1N2CC12C3C4C5C3C1C5C42
2025,CHEMBL2030627,P23975,,JJTSIVODPMDGBG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478277,DTCC01235116,1417143,48255,50.0,C1CC2CCC1N2CCC3=CC=CC=C3,c1ccc(CCN2C3CCC2CC3)cc1
2026,CHEMBL2030628,P23975,,URNOPSHFIGOPOJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478626,DTCC01235117,1221331,48255,50.0,C1CC2CCC1N2CCC3=CC(=CC=C3)F,Fc1cccc(CCN2C3CCC2CC3)c1
2027,CHEMBL2030629,P23975,,SRRZEMVAQOSBLB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478673,DTCC01235118,963513,48255,50.0,C1CC2CCC1N2CCC3=CC=CC=N3,c1ccc(CCN2C3CCC2CC3)nc1
2028,CHEMBL2030630,P23975,,LCBQDWKMNGEPLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478699,DTCC01235119,1961153,48255,50.0,C1CC2CCC1N2CCCC3=CC(=CC=C3)F,Fc1cccc(CCCN2C3CCC2CC3)c1
2029,CHEMBL2030631,P23975,N-BENZYLPYRROLIDINE,CWEGCQIIDCZZED-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478746,DTCC00041635,1993939,48255,50.0,C1CCN(C1)CC2=CC=CC=C2,c1ccc(CN2CCCC2)cc1
2030,CHEMBL2030632,P23975,N-(3-FLUOROBENZYL)PYRROLIDINE,PRKCBGIXZFUCEF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478783,DTCC00041636,1417144,48255,50.0,C1CCN(C1)CC2=CC(=CC=C2)F,Fc1cccc(CN2CCCC2)c1
2031,CHEMBL2030633,P23975,"N-(3,4-DIMETHOXYBENZYL)PYRROLIDINE",MIZXZRHARATZMK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10478830,DTCC00041637,801620,48255,50.0,COC1=C(C=C(C=C1)CN2CCCC2)OC,COc1ccc(CN2CCCC2)cc1OC
2032,CHEMBL2030634,P23975,N-(CYCLOHEXYLMETHYL)PYRROLIDINE,ADGIWWYGVBZYMC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10479218,DTCC00041638,769521,48255,50.0,C1CCC(CC1)CN2CCCC2,C1CCC(CN2CCCC2)CC1
2033,CHEMBL2030635,P23975,N-(2-PHENYLETHYL)PYRROLIDINE,KLUCWWVQVUXBSE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10479265,DTCC00041639,995674,48255,50.0,C1CCN(C1)CCC2=CC=CC=C2,c1ccc(CCN2CCCC2)cc1
2034,CHEMBL2030636,P23975,,PXBKRGXXBYALIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10479312,DTCC00129963,1156787,48255,50.0,C1CCN(C1)CCC2=CC(=CC=C2)F,Fc1cccc(CCN2CCCC2)c1
2035,CHEMBL2030637,P23975,,VBKWQJLSFFFYLC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10479395,DTCC00129964,834331,48255,50.0,C1CCN(C1)CCCC2=CC(=CC=C2)F,Fc1cccc(CCCN2CCCC2)c1
2036,CHEMBL2031737,P23975,,GPZMWOXSIRVXQW-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22313227.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant NET,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012.0,55.0,5.0,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818831.0,DTCT0023180,10474293,DTCC01236182,1106160,48153,10000.0,C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C(=O)C4=CC=C(C=C4)[N+](=O)[O-],C[C@@H]1CCCN1CCc1cc2cc(C(=O)c3ccc([N+](=O)[O-])cc3)ccc2o1
2096,CHEMBL2047561,P23975,,NBIWTPBSAFCSRX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762.0,IC50,=,327.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275.0,DTCT0023180,10527340,DTCC00130266,167263,48646,327.0,C1CN(CC=C1CC2=CC=CC=C2)CCC(C3=CC4=CC=CC=C4S3)O,OC(CCN1CC=C(Cc2ccccc2)CC1)c1cc2ccccc2s1
2105,CHEMBL2047570,P23975,,QXCOEFGWAUGVTR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762.0,IC50,=,385.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275.0,DTCT0023180,10527331,DTCC00130275,1429720,48646,385.0,C1CN(CC=C1CC2=CC=CC=C2)CCC(C3=CSC4=CC=CC=C43)O,OC(CCN1CC=C(Cc2ccccc2)CC1)c1csc2ccccc12
2106,CHEMBL2047571,P23975,,JYIMWQCCVNSNJW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762.0,IC50,=,420.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275.0,DTCT0023180,10527330,DTCC01242745,1332453,48646,420.0,COC1=C(C2=C(C=C1)C=C(C=C2)C(CCN3CCC(=CC3)CC4=CC=CC=C4)O)Cl,COc1ccc2cc(C(O)CCN3CC=C(Cc4ccccc4)CC3)ccc2c1Cl
2108,CHEMBL2047573,P23975,,JZHYJRPFUZJBQH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762.0,IC50,=,265.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275.0,DTCT0023180,10527328,DTCC01242747,1138570,48646,265.0,C1CN(CCC1(CC2=CC=CC=C2)O)CCC(C3=CC(=C(C=C3)Cl)Cl)O,OC(CCN1CCC(O)(Cc2ccccc2)CC1)c1ccc(Cl)c(Cl)c1
2109,CHEMBL2047574,P23975,,NQXSFBZVBLPNCG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22608762.0,IC50,=,178.0,NM,,cell_based,,,,,,,,,,,CHO,Inhibition of [3H]noradrenaline uptake at human NET expressed in CHO cells after 10 mins by scintillation counting,,Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors.,Eur. J. Med. Chem.,2012.0,54.0,,"Zheng YY, Guo L, Zhen XC, Li JQ",,827275.0,DTCT0023180,10527327,DTCC01242748,524316,48646,178.0,C1CN(CC=C1CC2=CC=CC=C2)CCC(C3=CC(=C(C=C3)Cl)Cl)O,OC(CCN1CC=C(Cc2ccccc2)CC1)c1ccc(Cl)c(Cl)c1
2194,CHEMBL2087421,P23975,,TYDKAHFZLFMNQX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22369198.0,INHIBITION,=,2.0,%,,cell_based,,,,,,,,,,,,Inhibition of human NE transporter at 5 uM by cell based assay,,From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.,J. Med. Chem.,2012.0,55.0,6.0,"Barth M, Bondoux M, Luccarini JM, Peyrou V, Dodey P, Pruneau D, Massardier C, Paquet JL",,841761.0,DTCT0023180,10599218,DTCC01254414,1578316,50456,2.0,CC1=CC(=CC(=C1S(=O)(=O)N(C)CCOCC(=O)N2CCN(CC2)C3CCN(CC3)C)C)OC,COc1cc(C)c(S(=O)(=O)N(C)CCOCC(=O)N2CCN(C3CCN(C)CC3)CC2)c(C)c1
2313,CHEMBL2165447,P23975,,KZONDTNPVHWVKU-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,EFFICACY,=,97.2,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880443.0,DTCT0023180,11471914,DTCC01290805,912917,51811,97.2,C1CN[C@@H]1COC2=NOC(=C2)COC3=CC=CC=C3,c1ccc(OCc2cc(OC[C@@H]3CCN3)no2)cc1
2314,CHEMBL2165447,P23975,,KZONDTNPVHWVKU-NSHDSACASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,191.0,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880413.0,DTCT0023180,11471911,DTCC01290805,912917,51811,191.0,C1CN[C@@H]1COC2=NOC(=C2)COC3=CC=CC=C3,c1ccc(OCc2cc(OC[C@@H]3CCN3)no2)cc1
2343,CHEMBL2172192,P23975,,CHVVPMVMKPMDFR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22664127.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to NET at 1 uM by radioligand displacement assay,Not Active,"Antagonists of 5-HT(6) receptors. Substituted 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[3,4-e]pyrimidines and 3-(phenylsulfonyl)pyrazolo[1,5-a]pyrido[4,3-d]pyrimidines-Synthesis and 'structure-activity' relationship.",Bioorg. Med. Chem. Lett.,2012.0,22.0,13.0,"Ivachtchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Vorobiev AA, Okun I",,863374.0,DTCT0023180,11411327,DTCC01293389,576450,51365,,CNC1=NN2C=C3CN(CCC3=NC2=C1S(=O)(=O)C4=CC=CC=C4)C,CNc1nn2cc3c(nc2c1S(=O)(=O)c1ccccc1)CCN(C)C3
2348,CHEMBL2179217,P23975,,ZPUAIXYROPYWKA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23006002.0,KI,=,2006.0,NM,,,,,,,,,,,,,,Binding affinity to NOR transporter,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875716.0,DTCT0023180,11435582,DTCC01295975,641546,51583,2006.0,CC1=CN(C2=C1C=C(C=C2)Cl)S(=O)(=O)C3=CC(=C(C=C3)OC)NC4CCN(CC4)C,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)ccc32)cc1NC1CCN(C)CC1
2349,CHEMBL2179222,P23975,,XRDVQWJPAZZLKN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23006002.0,KI,=,2129.0,NM,,,,,,,,,,,,,,Binding affinity to NOR transporter,,"Design, Synthesis, and Pharmacological Evaluation of Piperidin-4-yl amino aryl sulfonamides: Novel, Potent, Selective, Orally Active, and Brain Penetrant 5-HT(6) Receptor Antagonists.",J. Med. Chem.,2012.0,55.0,21.0,"Nirogi R, Shinde A, Daulatabad A, Kambhampati R, Gudla P, Shaik M, Gampa M, Balasubramaniam S, Gangadasari P, Reballi V, Badange R, Bojja K, Subramanian R, Bhyrapuneni G, Muddana N, Jayarajan P",,875716.0,DTCT0023180,11435581,DTCC01295978,1028954,51583,2129.0,CC1=CN(C2=C1C=C(C=N2)Cl)S(=O)(=O)C3=CC(=C(C=C3)OC)NC4CCN(CC4)C,COc1ccc(S(=O)(=O)n2cc(C)c3cc(Cl)cnc32)cc1NC1CCN(C)CC1
2439,CHEMBL2203551,P23975,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,EFFICACY,=,95.9,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET at 10 uM after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880443.0,DTCT0023180,11471915,DTCC01298943,621402,51811,95.9,C1C[C@H](NC1)COC2=NOC(=C2)COC3=CC=CC=C3,c1ccc(OCc2cc(OC[C@@H]3CCCN3)no2)cc1
2440,CHEMBL2203551,P23975,,JUWUZLUBIRHYMM-LBPRGKRZSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,203.0,NM,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET after 1.5 hrs by microbeta scintillation counting analysis,,,ACS Med. Chem. Lett.,2012.0,3.0,12.0,,,880413.0,DTCT0023180,11471910,DTCC01298943,621402,51811,203.0,C1C[C@H](NC1)COC2=NOC(=C2)COC3=CC=CC=C3,c1ccc(OCc2cc(OC[C@@H]3CCCN3)no2)cc1
2441,CHEMBL2203713,P23975,,BLZNLOLTHDUEOL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22840695.0,INHIBITION,=,18.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins,,"Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine.",Eur. J. Med. Chem.,2012.0,55.0,,"Annedi SC, Maddaford SP, Ramnauth J, Renton P, Rybak T, Silverman S, Rakhit S, Mladenova G, Dove P, Andrews JS, Zhang D, Porreca F",,883010.0,DTCT0023180,11458186,DTCC00131535,738126,51915,18.0,C1CNCCC1N2CCC3=C2C=CC(=C3)N=C(C4=CC=CS4)N,NC(=Nc1ccc2c(c1)CCN2C1CCNCC1)c1cccs1
2445,CHEMBL2204360,P23975,,JOJYHYRCIYAVHN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21486038.0,INHIBITION,=,88.0,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder.",J. Med. Chem.,2011.0,54.0,9.0,"Bang-Andersen B, Ruhland T, Jørgensen M, Smith G, Frederiksen K, Jensen KG, Zhong H, Nielsen SM, Hogg S, Mørk A, Stensbøl TB",,880221.0,DTCT0023180,11459019,DTCC01299713,1748126,51828,88.0,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Cl,Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1
2446,CHEMBL2205811,P23975,,ZKOQRCXMSDAJIR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,=,3638.0,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472831,DTCC01301027,1267730,51935,3638.0,COC1=CC=CC(=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)c1
2447,CHEMBL2205812,P23975,,TWMXGXSGGIIQDM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472810,DTCC01301028,556858,51935,10000.0,COC1=CC=C(C=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1
2448,CHEMBL2205813,P23975,,FOTUXOOYRRRHFQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047.0,DTCT0023180,11474476,DTCC01301029,1688236,51935,50.0,COC1=CC=CC(=C1OC)CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)c1OC
2449,CHEMBL2205814,P23975,,KULMFBVVFDTVNX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472787,DTCC01301030,1623988,51935,,COC1=C(C=C(C=C1)CCN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CCN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
2451,CHEMBL2205816,P23975,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472747,DTCC01301032,880294,51935,,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=CC=N7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccn1
2452,CHEMBL2205816,P23975,,ABONQAUMSMWLEK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12598260,DTCC01301032,881049,55935,,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC=CC=N7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1ccccn1
2453,CHEMBL2205817,P23975,,GFQHCUYWLHSGJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472736,DTCC01301033,912942,51935,,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CN=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccnc1
2460,CHEMBL2205823,P23975,,WWXCWTRLUXMAHX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047.0,DTCT0023180,11475944,DTCC01301039,1780156,51935,50.0,COC1=CC=CC=C1CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccccc1CN1C2C3C4CC5C6C4C2C6C1(O)C53
2461,CHEMBL2205824,P23975,,LIKZWSUAMNZHAE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11474238,DTCC01301040,1688238,51935,,COC1=CC=CC(=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1cccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)c1
2462,CHEMBL2205825,P23975,,GYKFQDQFKGGVKD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11474225,DTCC01301041,750568,51935,,COC1=CC=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1
2464,CHEMBL2205827,P23975,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11473007,DTCC01301043,1812524,51935,10000.0,COC1=C(C=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
2465,CHEMBL2205827,P23975,,MGYAQEPRQTVZOM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12600307,DTCC01301043,1813367,55935,10000.0,COC1=C(C=C(C=C1)CN2C3C4C5CC6C4C2(C7C6C5C73)O)OC,COc1ccc(CN2C3C4C5CC6C7C5C3C7C2(O)C64)cc1OC
2467,CHEMBL2205829,P23975,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472979,DTCC01301045,330310,51935,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC8=C(C=C7)OCO8)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccc2c(c1)OCO2
2468,CHEMBL2205829,P23975,,AVNYJOIRGGOFFW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12600273,DTCC01301045,331095,55935,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC8=C(C=C7)OCO8)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccc2c(c1)OCO2
2473,CHEMBL2205832,P23975,,ZUHLFYHHSNMSRE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047.0,DTCT0023180,11475806,DTCC01301048,589038,51935,50.0,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC=CC=N7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1ccccn1
2474,CHEMBL2205833,P23975,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET at 10 uM,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884047.0,DTCT0023180,11475767,DTCC01301049,2039955,51935,50.0,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CN=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccnc1
2475,CHEMBL2205833,P23975,,DCGVCGVBZDMLGR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601138,DTCC01301049,2040747,55935,50.0,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CN=CC=C7)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccnc1
2479,CHEMBL2205836,P23975,,PSBBAGWMKGXQRW-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,=,9905.0,NM,,,,,,,,,,,,,,Binding affinity to NET,,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11472851,DTCC01301052,1041425,51935,9905.0,COC1=CC=CC=C1CCN2C3C4C5CC6C4C2(C7C6C5C73)O,COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53
2480,CHEMBL2206397,P23975,RO-4992479,NIRASHDWADNQJU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22795332.0,INHIBITION,=,-1.0,%,,,,,,,,,,,,,,Inhibition of human NE transporter at 10 uM by CEREP assay,,Optimisation of imidazole compounds as selective TAAR1 agonists: discovery of RO5073012.,Bioorg. Med. Chem. Lett.,2012.0,22.0,16.0,"Galley G, Stalder H, Goergler A, Hoener MC, Norcross RD",,881984.0,DTCT0023180,11478572,DTCC00045622,835169,51910,-1.0,CCC1=C(C(=CC=C1)CC)CC2=NC=CN2,CCc1cccc(CC)c1Cc1ncc[nH]1
2513,CHEMBL2207376,P23975,,MJYQMQCVUXOIFY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912.0,INHIBITION,=,13.5,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892.0,DTCT0023180,11493421,DTCC01302559,750581,52134,13.5,CN1CCN(CC1)CC2=C3C(=CC=C2)N(C=C3Cl)S(=O)(=O)C4=CC(=CC=C4)Cl,CN1CCN(Cc2cccc3c2c(Cl)cn3S(=O)(=O)c2cccc(Cl)c2)CC1
2514,CHEMBL2207382,P23975,,MBFLODNVCSXSKE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912.0,INHIBITION,=,6.78,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892.0,DTCT0023180,11493420,DTCC01302565,1041441,52134,6.78,CN1CCN(CC1)CC2=C3C(=CC=C2)N(C=C3Br)S(=O)(=O)C4=CC=CC=C4,CN1CCN(Cc2cccc3c2c(Br)cn3S(=O)(=O)c2ccccc2)CC1
2515,CHEMBL2207386,P23975,,AGKMPGSBLMAGAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912.0,INHIBITION,=,10.83,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892.0,DTCT0023180,11493423,DTCC01302569,718295,52134,10.83,CN1CCN(CC1)CC2=C3C=CN(C3=CC=C2)S(=O)(=O)C4=CC=CC=C4Br,CN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2Br)CC1
2516,CHEMBL2207388,P23975,,CULSPSVPJXBZMJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912.0,INHIBITION,=,10.16,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892.0,DTCT0023180,11493422,DTCC01302571,814971,52134,10.16,CN1CCN(CC1)CC2=C3C=CN(C3=CC=C2)S(=O)(=O)C4=CC=CC=C4,CN1CCN(Cc2cccc3c2ccn3S(=O)(=O)c2ccccc2)CC1
2558,CHEMBL226335,P23975,RUTIN,IKGXIBQEEMLURG-NVPNHPEKSA-N,2,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14750355,DTCC00448737,2109891,69275,10000.0,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
2590,CHEMBL230951,P23975,L-HOMOCYSTEATE,VBOQYPQEPHKASR-VKHMYHEASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730850,DTCC00002972,2104237,69159,10000.0,C(CS(=O)(=O)O)[C@@H](C(=O)O)N,N[C@@H](CCS(=O)(=O)O)C(=O)O
2604,CHEMBL232104,P23975,,BRIVIXLMMUIBJY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17606674.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET at 10 uM,Not Active,"Efficacy, pharmacokinetics, and metabolism of tetrahydroquinoline inhibitors of Plasmodium falciparum protein farnesyltransferase.",Antimicrob. Agents Chemother.,2007.0,51.0,10.0,"Van Voorhis WC, Rivas KL, Bendale P, Nallan L, Hornéy C, Barrett LK, Bauer KD, Smart BP, Ankala S, Hucke O, Verlinde CL, Chakrabarti D, Strickland C, Yokoyama K, Buckner FS, Hamilton AD, Williams DK, Lombardo LJ, Floyd D, Gelb MH",,498996.0,DTCT0023180,2717333,DTCC00461356,1166865,34114,,CN1C=NC=C1CN2CC(CC3=C2C=CC(=C3)C#N)N(CC4CCN(CC4)C(=O)OC)S(=O)(=O)C5=CC=CC=N5,COC(=O)N1CCC(CN(C2Cc3cc(C#N)ccc3N(Cc3cncn3C)C2)S(=O)(=O)c2ccccn2)CC1
2622,CHEMBL2326501,P23975,,KRCLPAGVJVBLJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23237837.0,INHIBITION,=,52.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant NE transporter expressed in CHO cells at 1 uM,,Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.,Bioorg. Med. Chem. Lett.,2013.0,23.0,2.0,"Butini S, Gemma S, Brindisi M, Maramai S, Minetti P, Celona D, Napolitano R, Borsini F, Cabri W, Fezza F, Merlini L, Dallavalle S, Campiani G, Maccarrone M",,939645.0,DTCT0023180,11784448,DTCC01344807,1353507,53501,52.0,CCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC(=C2)N3CCNCC3,CCCCCCCOc1ccc(NC(=O)Oc2cccc(N3CCNCC3)c2)cc1
2755,CHEMBL2391147,P23975,,ZTGRWYMPQCQTHD-ONGXEEELSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23582449.0,INHIBITION,=,-17.0,%,,,,,,,,,,,,,,Binding affinity to human nonepinephrine transporter at 10 uM by radioligand displacement assay relative to control,,Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.,Bioorg. Med. Chem.,2013.0,21.0,10.0,"Veinberg G, Vorona M, Zvejniece L, Vilskersts R, Vavers E, Liepinsh E, Kazoka H, Belyakov S, Mishnev A, Kuznecovs J, Vikainis S, Orlova N, Lebedev A, Ponomaryov Y, Dambrova M",,964345.0,DTCT0023180,12465368,DTCC01378839,220399,54817,-17.0,C[C@H]1[C@H](CC(=O)N1CC(=O)N)C2=CC=CC=C2,C[C@H]1[C@@H](c2ccccc2)CC(=O)N1CC(N)=O
2756,CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,IC50,=,42657.95,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465478,DTCC01379235,1386484,54821,42657.95,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
2757,CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,KI,=,12008.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465477,DTCC01379235,1386484,54821,12008.0,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
2758,CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human recombinant norepinephrine transporter expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964941.0,DTCT0023180,12464697,DTCC01379235,1386484,54821,10000.0,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
2759,CHEMBL2391541,P23975,,HGRHWEAUHXYNNP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26739781.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) by competition binding assay,,"Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.",Bioorg. Med. Chem. Lett.,2016.0,26.0,3.0,"Cozzi NV, Daley PF.",,1550158.0,DTCT0023180,62501,DTCC01379235,1369782,65871,10000.0,COC1=CC2=C(C=C1)NC=C2CCN(CC=C)CC=C,C=CCN(CC=C)CCc1c[nH]c2ccc(OC)cc12
2760,CHEMBL2392692,P23975,,PVTFEAGMCGMRRS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23664879.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 1 uM relative to control,,"Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.",Bioorg. Med. Chem. Lett.,2013.0,23.0,12.0,"Thalji RK, McAtee JJ, Belyanskaya S, Brandt M, Brown GD, Costell MH, Ding Y, Dodson JW, Eisennagel SH, Fries RE, Gross JW, Harpel MR, Holt DA, Israel DI, Jolivette LJ, Krosky D, Li H, Lu Q, Mandichak T, Roethke T, Schnackenberg CG, Schwartz B, Shewchuk LM, Xie W, Behm DJ, Douglas SA, Shaw AL, Marino JP",,965571.0,DTCT0023180,12464849,DTCC01380390,1353885,54882,50.0,CC1=NC(=NC(=N1)N2CCC(CC2)C(=O)NCC3=C(C=C(C=C3)Br)OC(F)(F)F)NC,CNc1nc(C)nc(N2CCC(C(=O)NCc3ccc(Br)cc3OC(F)(F)F)CC2)n1
2764,CHEMBL2397268,P23975,,JAKRIQWSQWQJHM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23627311.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter (unknown origin) at 5 uM by psychoactive drug screening programme assay,,Synthesis and structure activity relationship of tetrahydroisoquinoline-based potentiators of GluN2C and GluN2D containing N-methyl-D-aspartate receptors.,J. Med. Chem.,2013.0,56.0,13.0,"Santangelo Freel RM, Ogden KK, Strong KL, Khatri A, Chepiga KM, Jensen HS, Traynelis SF, Liotta DC",,968888.0,DTCT0023180,12483459,DTCC01381880,1353904,54936,50.0,COC1=CC=C(C=C1)OCC2C3=C(CCN2C(=O)C4=CC(=CC=C4)Br)C=C(C=C3)OCC5=CC=CC=C5,COc1ccc(OCC2c3ccc(OCc4ccccc4)cc3CCN2C(=O)c2cccc(Br)c2)cc1
2802,CHEMBL2429890,P23975,,VGYQUDBPYFLBLJ-PTCVETCVSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,=,7352.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12601184,DTCC01398005,1268545,55935,7352.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC7=C(C=C6)OCO7,c1cc2c(cc1CN[C@H]1C3C4CC5C6C4CC3C6C51)OCO2
2869,CHEMBL2432038,P23975,,OKCSFONJDXUZOU-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601129,DTCC01398006,913793,55935,50.0,C1CCC(CC1)CN[C@H]2C3C4CC5C2C6C3CC4C56,C1CCC(CN[C@H]2C3C4CC5C6C4CC3C6C52)CC1
2870,CHEMBL2432039,P23975,,CHZUEGVOEFMIJH-ZKRSMWHSSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601128,DTCC01398007,1845582,55935,50.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC67C8C9C6C1C9C8C71,C1C2C3CC4C2C2C1C3[C@H](NCC13C5C6C7C5C1C7C63)C42
2872,CHEMBL2432040,P23975,,MPBJQDFYALBXED-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601156,DTCC01398008,1139742,55935,50.0,CN(CC1=CC=CC=C1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(Cc1ccccc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2873,CHEMBL2432041,P23975,,MSTPNDDVMWUDFF-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601155,DTCC01398009,71453,55935,50.0,CN(CC1=CC(=CC=C1)F)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(Cc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2874,CHEMBL2432042,P23975,,LNTMHZZRTAQEJQ-CPVTZQMHSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601154,DTCC01398010,589816,55935,50.0,CN(CC1=CC(=C(C=C1)OC)OC)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,COc1ccc(CN(C)[C@H]2C3C4CC5C3C(=O)C3C5C4C32)cc1OC
2875,CHEMBL2432043,P23975,,LKFSLMWAVKMONG-KPCGFGSOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601153,DTCC01398011,2040745,55935,50.0,CN(CC1=CN=CC=C1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(Cc1cccnc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2876,CHEMBL2432044,P23975,,IDXFKHDXIHNWAI-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601152,DTCC01398012,2040746,55935,50.0,CN(CCC1=CC=CC=C1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCc1ccccc1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2877,CHEMBL2432045,P23975,,ZWCQZHOWEDKJBN-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601136,DTCC01398013,1657028,55935,50.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCC6=CC=CC=C6,c1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1
2878,CHEMBL2432046,P23975,,KNBHNNRMMAKKFI-SEDVZXITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601135,DTCC01398014,1009784,55935,50.0,COC1=C(C=C(C=C1)CN[C@H]2C3C4CC5C2C6C3CC4C56)OC,COc1ccc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC
2880,CHEMBL2432048,P23975,,KBAKPEFQDPCCTP-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601133,DTCC01398016,1495532,55935,50.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC=CC=C6,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)cc1
2881,CHEMBL2432049,P23975,,DUZKXKAAUHDBQA-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601132,DTCC01398017,298486,55935,50.0,C1C2C3CC4C2[C@@H](C5C1C3C45)NCCC6=CC=CC=N6,c1ccc(CCN[C@H]2C3C4CC5C6C4CC3C6C52)nc1
2883,CHEMBL2432051,P23975,,CPLYGLAQLNAQOI-SEDVZXITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601130,DTCC01398019,71454,55935,50.0,COC1=CC(=CC(=C1OC)OC)CN[C@H]2C3C4CC5C2C6C3CC4C56,COc1cc(CN[C@H]2C3C4CC5C6C4CC3C6C52)cc(OC)c1OC
2884,CHEMBL2432052,P23975,,SGFPDDMJMPKKTB-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601151,DTCC01398020,783458,55935,50.0,CN(CCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2885,CHEMBL2432053,P23975,,DEOOAAFCKARVDM-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601150,DTCC01398021,751332,55935,50.0,CN(CCC1=CC=CC=N1)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCc1ccccn1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2886,CHEMBL2432054,P23975,,QQUOSDRKLSIRED-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,=,8533.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12601183,DTCC01398022,945256,55935,8533.0,CN(CCCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C3C(=O)C6C2C4C56,CN(CCCc1cccc(F)c1)[C@H]1C2C3CC4C2C(=O)C2C4C3C21
2887,CHEMBL2432055,P23975,,VNGQWOKKSKAESQ-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601149,DTCC01398023,2040748,55935,50.0,CN(CC1=CC=CC=C1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41
2888,CHEMBL2432056,P23975,,JHFKLSFCMAHSDK-LLOIJXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601147,DTCC01398024,103846,55935,50.0,CN(CC1=CC(=C(C=C1)OC)OC)[C@H]2C3C4CC5C2C6C3CC4C56,COc1ccc(CN(C)[C@H]2C3C4CC5C6C4CC3C6C52)cc1OC
2889,CHEMBL2432057,P23975,,QHQJBDOHEUWLBB-CAUKCHDASA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601146,DTCC01398025,71455,55935,50.0,CN(CC1=CN=CC=C1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(Cc1cccnc1)[C@H]1C2C3CC4C5C3CC2C5C41
2890,CHEMBL2432058,P23975,,MJOVYQVAQIHDSE-DKSPCFMDSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601145,DTCC01398026,2008169,55935,50.0,CN(CCC1=CC=CC=C1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1ccccc1)[C@H]1C2C3CC4C5C3CC2C5C41
2891,CHEMBL2432059,P23975,,YLVXPEMITKSDOS-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601143,DTCC01398027,2008170,55935,50.0,CN(CCC1=CC=CC=N1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCc1ccccn1)[C@H]1C2C3CC4C5C3CC2C5C41
2892,CHEMBL2432060,P23975,,CKFQOWSPJPMWEK-IINHSQADSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601142,DTCC01398028,1235634,55935,50.0,CN(CCCC1=CC(=CC=C1)F)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CCCc1cccc(F)c1)[C@H]1C2C3CC4C5C3CC2C5C41
2893,CHEMBL2432061,P23975,,ZFZXJOHWFSRUAO-LLOIJXFCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601141,DTCC01398029,1720366,55935,50.0,CN(CC1=CC(=C(C(=C1)OC)OC)OC)[C@H]2C3C4CC5C2C6C3CC4C56,COc1cc(CN(C)[C@H]2C3C4CC5C6C4CC3C6C52)cc(OC)c1OC
2894,CHEMBL2432062,P23975,,SSQDVMAIIMMISV-SEDVZXITSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601140,DTCC01398030,1780918,55935,50.0,CN(CC1=CC2=C(C=C1)OCO2)[C@H]3C4C5CC6C3C7C4CC5C67,CN(Cc1ccc2c(c1)OCO2)[C@H]1C2C3CC4C5C3CC2C5C41
2895,CHEMBL2432063,P23975,,BMHWWKPJPARTBN-RAOGCBAWSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,INHIBITION,<,50.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes at 10 uM relative to control,,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985446.0,DTCT0023180,12601139,DTCC01398031,331096,55935,50.0,CN(CC1CCCCC1)[C@H]2C3C4CC5C2C6C3CC4C56,CN(CC1CCCCC1)[C@H]1C2C3CC4C5C3CC2C5C41
2896,CHEMBL243712,P23975,AMISULPRIDE,NTJOBXMMWNYJFB-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19337725.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14728306,DTCC00458164,2103595,69290,10000.0,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
2897,CHEMBL2440659,P23975,,AXVLPJHYYFHCHK-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24074843.0,INHIBITION,>,35.0,%,,cell_based,,,,,,,,,,,,Displacement of [125I]-RTI-55 from human recombinant NET expressed in MDCK cells at 10 uM relative to control,,Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.,Bioorg. Med. Chem. Lett.,2013.0,23.0,21.0,"Felts AS, Rodriguez AL, Morrison RD, Venable DF, Manka JT, Bates BS, Blobaum AL, Byers FW, Daniels JS, Niswender CM, Jones CK, Conn PJ, Lindsley CW, Emmitte KA",,990301.0,DTCT0023180,12632816,DTCC01401025,1592232,56261,35.0,CC1=CSC(=N1)NC(=O)C2=CC(=CC(=C2)F)OC3=CN=CN=C3,Cc1csc(NC(=O)c2cc(F)cc(Oc3cncnc3)c2)n1
2898,CHEMBL2442940,P23975,,INPPXFAIFVJMMD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24050790.0,INHIBITION,,,,,,,,,,,,,,,,,Binding affinity to human norepinephrine transporter at 10 uM by radioligand binding assay,Not Active,"Identification of a novel benzoxazolone derivative as a selective, orally active 18 kDa translocator protein (TSPO) ligand.",J. Med. Chem.,2013.0,56.0,20.0,"Fukaya T, Ishiyama T, Baba S, Masumoto S",,991142.0,DTCT0023180,12640920,DTCC01403311,103900,56238,,CN(C1=CC=C(C=C1)C(F)(F)F)C(=O)CN2C3=C(C=CC(=C3)C4=CN=CC=C4)OC2=O,CN(C(=O)Cn1c(=O)oc2ccc(-c3cccnc3)cc21)c1ccc(C(F)(F)F)cc1
2915,CHEMBL246955,P23975,,XYYGFCDTBHAUSN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17127059.0,KI,=,106.0,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007.0,17.0,4.0,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453471.0,DTCT0023180,2219075,DTCC00477235,1361791,24220,106.0,CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCOCC3)C4=CC=C(C=C4)SC,CSc1ccc(C2CN(C)Cc3cc(OCCCN4CCOCC4)ccc32)cc1
2949,CHEMBL250450,P23975,ISOQUERCETIN,OVSQVDMCBVZWGM-QSOFNFLRSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753423,DTCC00486067,2109951,69275,10000.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O)O,O=c1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
2951,CHEMBL251254,P23975,HYPEROSIDE,OVSQVDMCBVZWGM-DTGCRPNFSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14748619,DTCC00487046,2109632,69275,10000.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O)O)O)O,O=c1c(O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
2974,CHEMBL253597,P23975,,DHZBNHMEIOBPAE-JVVVGQRLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18067245.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET receptor at 10 uM,,Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo.,J. Med. Chem.,2008.0,51.0,1.0,"Briard E, Zoghbi SS, Imaizumi M, Gourley JP, Shetty HU, Hong J, Cropley V, Fujita M, Innis RB, Pike VW",,460133.0,DTCT0023180,2267479,DTCC00485513,1458632,24978,50.0,CC(=O)N(CC1=CC=CC=C1O[11CH3])C2=C(C=CN=C2)OC3=CC=CC=C3,COc1ccccc1CN(C(C)=O)c1cnccc1Oc1ccccc1
3053,CHEMBL257940,P23975,,WZHXVKWOVBWNIB-RHDGDCLCSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18160282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of norepinephrine transporter at 10 uM,,Discovery of novel orally active ureido NPY Y5 receptor antagonists.,Bioorg. Med. Chem. Lett.,2008.0,18.0,3.0,"Li G, Stamford AW, Huang Y, Cheng KC, Cook J, Farley C, Gao J, Ghibaudi L, Greenlee WJ, Guzzi M, van Heek M, Hwa JJ, Kelly J, Mullins D, Parker EM, Wainhaus S, Zhang X",,468038.0,DTCT0023180,2301305,DTCC00499075,424837,25590,10.0,CC(=O)N1CCC(CC1)N(C)C(=O)NC2CCC(CC2)C3=CC(=CC(=C3)F)F,CC(=O)N1CCC(N(C)C(=O)NC2CCC(c3cc(F)cc(F)c3)CC2)CC1
3129,CHEMBL267615,P23975,,ZEYRDXUWJDGTLD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10715164.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Compound was evaluated for its binding affinity towards human NET(norepinephrine) transporter,,2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.,J. Med. Chem.,2000.0,43.0,5.0,"Glennon RA, Lee M, Rangisetty JB, Dukat M, Roth BL, Savage JE, McBride A, Rauser L, Hufeisen S, Lee DK",,140883.0,DTCT0023180,884518,DTCC00133863,905249,16105,10000.0,CCC1=C(C2=C(N1)C=CC(=C2)OC)CCN(C)C,CCc1[nH]c2ccc(OC)cc2c1CCN(C)C
3155,CHEMBL270595,P23975,,OXEFHEYEQUISKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22607684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,2012.0,22.0,12.0,"Banister SD, Rendina LM, Kassiou M",,818156.0,DTCT0023180,10479349,DTCC00502273,1928089,48255,50.0,C1CCN(C1)CCC2=CC=CC=N2,c1ccc(CCN2CCCC2)nc1
3186,CHEMBL274119,P23975,RACEMETHIONINE,FFEARJCKVFRZRR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14733405,DTCC00135493,2104905,69159,10000.0,CSCCC(C(=O)O)N,CSCCC(N)C(=O)O
3187,CHEMBL274525,P23975,ABT-418,ILLGYRJAYAAAEW-QMMMGPOBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,7518514.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14740807,DTCC00137246,2107062,69433,10000.0,CC1=NOC(=C1)[C@@H]2CCCN2C,Cc1cc([C@@H]2CCCN2C)on1
3230,CHEMBL289469,P23975,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7329705,DTCC00177095,249942,46191,,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2
3231,CHEMBL289469,P23975,GRANISETRON,MFWNKCLOYSRHCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7329706,DTCC00177095,249942,46191,,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C,CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2
3279,CHEMBL299052,P23975,,VHGCDTVCOLNTBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,2.03,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731327,DTCC00202425,2104389,68566,2.03,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,CNCCC(Oc1ccccc1C)c1ccccc1
3280,CHEMBL299052,P23975,,VHGCDTVCOLNTBX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845.0,KI,=,5.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14731326,DTCC00202425,2104388,68736,5.0,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2,CNCCC(Oc1ccccc1C)c1ccccc1
3282,CHEMBL3,P23975,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7394755,DTCC00132283,51492,46191,,CN1CCC[C@H]1C2=CN=CC=C2,CN1CCC[C@H]1c1cccnc1
3283,CHEMBL3,P23975,NICOTINE,SNICXCGAKADSCV-JTQLQIEISA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7394756,DTCC00132283,51492,46191,,CN1CCC[C@H]1C2=CN=CC=C2,CN1CCC[C@H]1c1cccnc1
3310,CHEMBL30713,P23975,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,IC50,=,3715.35,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465480,DTCC01739501,1995571,54821,3715.35,CC(CC1=CNC2=CC=CC=C21)N,CC(N)Cc1c[nH]c2ccccc12
3311,CHEMBL30713,P23975,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,KI,=,642.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465479,DTCC01739501,1995571,54821,642.0,CC(CC1=CNC2=CC=CC=C21)N,CC(N)Cc1c[nH]c2ccccc12
3312,CHEMBL30713,P23975,ALPHA-METHYLTRYPTAMINE,QSQQQURBVYWZKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,KI,>,10000.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]Nisoxetine from human recombinant norepinephrine transporter expressed in HEK293 cells after 1 to 1.5 hrs by scintillation counting analysis,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,964941.0,DTCT0023180,12464698,DTCC01739501,1995571,54821,10000.0,CC(CC1=CNC2=CC=CC=C21)N,CC(N)Cc1c[nH]c2ccccc12
3337,CHEMBL3094311,P23975,,NHUZHVAPAIJQRS-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,64.7,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962132,DTCC01413925,1127501,56656,64.7,C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)Cl.Cl,NCc1ccc(OCc2ccc(Cl)cc2)cc1
3338,CHEMBL3094312,P23975,,KKYAPAJUTFYVRD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,29.3,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962090,DTCC01413926,351566,56656,29.3,C1=CC=C(C(=C1)COC2=CC=C(C=C2)CN)OC(F)(F)F.Cl,NCc1ccc(OCc2ccccc2OC(F)(F)F)cc1
3339,CHEMBL3094313,P23975,,XVKBXJCHXRLYAQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,58.5,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962048,DTCC01413927,933254,56656,58.5,C1=CC(=CC(=C1)OC(F)(F)F)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2cccc(OC(F)(F)F)c2)cc1
3340,CHEMBL3094314,P23975,,NLGKYLSBSOGION-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,60.1,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962006,DTCC01413928,901389,56656,60.1,C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)OC(F)(F)F.Cl,NCc1ccc(OCc2ccc(OC(F)(F)F)cc2)cc1
3341,CHEMBL3094316,P23975,,RSZFCDGHJLBYEB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,63.6,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12963234,DTCC01413930,1708845,56656,63.6,C1=CC=C(C=C1)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2ccccc2)cc1
3342,CHEMBL3094317,P23975,,VCEAPZBMHGKMHI-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,61.3,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962301,DTCC01413931,1256448,56656,61.3,C1=CC=C(C(=C1)COC2=CC=C(C=C2)CN)F.Cl,NCc1ccc(OCc2ccccc2F)cc1
3343,CHEMBL3094318,P23975,,CYPDLWIUOMSUJR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,76.1,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962259,DTCC01413932,1737126,56656,76.1,C1=CC(=CC(=C1)F)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2cccc(F)c2)cc1
3344,CHEMBL3094319,P23975,,YYONFKYBFNEIKC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,59.9,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962217,DTCC01413933,965453,56656,59.9,C1=CC(=CC=C1CN)OCC2=CC=C(C=C2)F.Cl,NCc1ccc(OCc2ccc(F)cc2)cc1
3345,CHEMBL3094320,P23975,,UZVSKGBBGCJIRV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24238903.0,INHIBITION,=,83.9,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM relative to control,,Benzyloxybenzylammonium chlorides: Simple amine salts that display anticonvulsant activity.,Bioorg. Med. Chem.,2013.0,21.0,24.0,"Lee H, Gold AS, Yang XF, Khanna R, Kohn H",,1279082.0,DTCT0023180,12962174,DTCC01413934,1644990,56656,83.9,C1=CC(=CC(=C1)Cl)COC2=CC=C(C=C2)CN.Cl,NCc1ccc(OCc2cccc(Cl)c2)cc1
3346,CHEMBL3099899,P23975,,VDWKDBPHAPPUBO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24215892.0,INHIBITION,=,-17.0,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM relative to control,,"Discovery of 2,5-diarylnicotinamides as selective orexin-2 receptor antagonists (2-SORAs).",Bioorg. Med. Chem. Lett.,2013.0,23.0,24.0,"Mercer SP, Roecker AJ, Garson S, Reiss DR, Meacham Harrell C, Murphy KL, Bruno JG, Bednar RA, Lemaire W, Cui D, Cabalu TD, Tang C, Prueksaritanont T, Hartman GD, Young SD, Winrow CJ, Renger JJ, Coleman PJ",,1282795.0,DTCT0023180,12972941,DTCC01415896,1737150,56711,-17.0,COC1=C(C=C(C=C1)CNC(=O)C2=C(N=CC(=C2)C3=CC(=CC(=C3)Cl)Cl)C4=CN=CC=C4)OC,COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC
3349,CHEMBL3104091,P23975,,DVSMVUMYJDOPJQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984212,DTCC01417357,351604,56928,10000.0,CN1CCC2=C(C1)C3=CC=CC4=C3N2C5=CC=CC=C5CC4,CN1CCc2c(c3cccc4c3n2-c2ccccc2CC4)C1
3350,CHEMBL3104092,P23975,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,=,1348.96,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984171,DTCC01417358,1030177,56928,1348.96,CN1CCC2=C(C1)C3=CC=CC4=C3N2CC5=CC=CC=C5C4,CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1
3351,CHEMBL3104092,P23975,,RQBRUGMHSQYCNU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,=,1349.0,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984089,DTCC01417358,1030177,56928,1349.0,CN1CCC2=C(C1)C3=CC=CC4=C3N2CC5=CC=CC=C5C4,CN1CCc2c(c3cccc4c3n2Cc2ccccc2C4)C1
3352,CHEMBL3104093,P23975,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,=,1949.84,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984130,DTCC01417359,577788,56928,1949.84,CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
3353,CHEMBL3104093,P23975,,XKGPHJMKJBEURD-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,=,1955.0,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984072,DTCC01417359,577788,56928,1955.0,CN1CCC2=C(C1)C3=C4N2CCC5=CC=CC=C5C4=CC=C3,CN1CCc2c(c3cccc4c3n2CCc2ccccc2-4)C1
3358,CHEMBL310604,P23975,HOMOCYSTEINE,FFFHZYDWPBMWHY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14743991,DTCC00239847,2108578,69159,10000.0,C(CS)C(C(=O)O)N,NC(CCS)C(=O)O
3396,CHEMBL3186763,P23975,,DCAMTBFFNOHDAW-DYTRJAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25244572.0,INHIBITION,=,91.1,%,,,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET at 10 uM,,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,2014.0,57.0,20.0,"Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE",,1439060.0,DTCT0023180,14011993,DTCC01442275,2029987,59962,91.1,CN1CCN(C(=NC2=C(C=C(C=C2)[N+](=O)[O-])C(=O)NC3=CC=CC=C3)C1)C,CN1CCN(C)C(=Nc2ccc([N+](=O)[O-])cc2C(=O)Nc2ccccc2)C1
3402,CHEMBL3215892,P23975,,MTATYSOUXXNXHF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23141912.0,INHIBITION,=,6.28,%,,,,,,,,,,,,,,Inhibition of NET at 1 uM by radioligand displacement assay,,"Design, synthesis and pharmacological evaluation of 4-(piperazin-1-yl methyl)-N(1)-arylsulfonyl indole derivatives as 5-HT(6) receptor ligands.",Bioorg. Med. Chem. Lett.,2012.0,22.0,24.0,"Nirogi RV, Badange R, Kambhampati R, Chindhe A, Deshpande AD, Tiriveedhi V, Kandikere V, Muddana N, Abraham R, Khagga M",,886892.0,DTCT0023180,11493419,DTCC01463309,1041440,52134,6.28,C1CN(CCN1)CC2=C3C=CN(C3=CC=C2)S(=O)(=O)C4=CC=CC=C4Br.Cl.Cl,O=S(=O)(c1ccccc1Br)n1ccc2c(CN3CCNCC3)cccc21
3433,CHEMBL3287723,P23975,,AOYJKNKRKBOUAP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24735492.0,INHIBITION,=,-4.8,%,,,,,,,,,,,,,,Binding affinity to human NET at 10 uM by radioligand displacement assay,,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,2014.0,57.0,10.0,"Dhanya RP, Sheffler DJ, Dahl R, Davis M, Lee PS, Yang L, Nickols HH, Cho HP, Smith LH, D'Souza MS, Conn PJ, Der-Avakian A, Markou A, Cosford ND",,1361699.0,DTCT0023180,13779806,DTCC01498697,200946,59335,-4.8,CC1=C(C=CC(=C1O)C(=O)CC(C)(C)C)OCCCCOC2=C(C=CC(=C2)C(=O)O)OC,COc1ccc(C(=O)O)cc1OCCCCOc1ccc(C(=O)CC(C)(C)C)c(O)c1C
3465,CHEMBL3310035,P23975,,RQPAEAIGXOANQF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from NET (unknown origin) expressed in HEK cells at 10 uM after 90 mins by microbeta counting analysis,Not Active,,J. Nat. Prod.,2014.0,77.0,5.0,,,1451619.0,DTCT0023180,13892113,DTCC01510285,655458,57486,,CC1=CC2=CC(=C(C(=C2C(=O)O1)O)O)CCC(=O)OC,COC(=O)CCc1cc2cc(C)oc(=O)c2c(O)c1O
3571,CHEMBL3311308,P23975,,FQUAFMNPXPXOJE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24881566.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of human NET by BacMam bind SPA/summary (Abse5) assay,,Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120).,Bioorg. Med. Chem. Lett.,2014.0,24.0,14.0,"Sparks SM, Chen G, Collins JL, Danger D, Dock ST, Jayawickreme C, Jenkinson S, Laudeman C, Leesnitzer MA, Liang X, Maloney P, McCoy DC, Moncol D, Rash V, Rimele T, Vulimiri P, Way JM, Ross S",,1455322.0,DTCT0023180,13918410,DTCC01511540,558563,60691,100000.0,CC1=CC(=C(C(=C1)C)NS(=O)(=O)C2=CC=C(C=C2)OC)C,COc1ccc(S(=O)(=O)Nc2c(C)cc(C)cc2C)cc1
3722,CHEMBL3334797,P23975,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761.0,IC50,=,477.5,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]-NE uptake in human norepinephrine transporter expressed in HEK293 cells by scintillation counting,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014.0,86.0,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1456969.0,DTCT0023180,13968275,DTCC01521941,1996944,59781,477.5,CN(C)CCC(C1=CC(=C(C=C1)Cl)Cl)N2CCOCC2,CN(C)CCC(c1ccc(Cl)c(Cl)c1)N1CCOCC1
3723,CHEMBL3334797,P23975,,KEGBICCDHKITSP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25164761.0,INHIBITION,=,96.7,%,,,,,,,,,,,,,,Displacement of [3H]Imipramin from human NET at 10 uM relative to control,,Synthesis and pharmacological investigation of aralkyl diamine derivatives as potential triple reuptake inhibitors.,Eur. J. Med. Chem.,2014.0,86.0,,"Zheng YY, Weng ZJ, Xie P, Zhu MY, Xing LX, Li JQ",,1458812.0,DTCT0023180,13968474,DTCC01521941,1996944,59781,96.7,CN(C)CCC(C1=CC(=C(C=C1)Cl)Cl)N2CCOCC2,CN(C)CCC(c1ccc(Cl)c(Cl)c1)N1CCOCC1
3821,CHEMBL3577955,P23975,,PWDBREUBRYUEGC-BTJKTKAUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496655.0,DTCT0023180,14434956,DTCC01646031,903869,62611,,CC(C)N1CCN(CC1)C(=O)C2=CC=C(C=C2)CN3CCOCC3.C(=C\C(=O)O)\C(=O)O,CC(C)N1CCN(C(=O)c2ccc(CN3CCOCC3)cc2)CC1
3822,CHEMBL3577956,P23975,,ABJWJGMTLYSISP-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496655.0,DTCT0023180,14434957,DTCC01646032,386606,62611,,C1CC(C1)N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4,O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CCC2)CC1
3823,CHEMBL3577957,P23975,,MRTJHEDYFUFHHQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25893048.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human NET at 1 uM,Not Active,,ACS Med. Chem. Lett.,2015.0,6.0,4.0,,,1496655.0,DTCT0023180,14434958,DTCC01646033,1550378,62611,,C1CC1N2CCN(CC2)C(=O)C3=CC=C(C=C3)CN4CCOCC4.Cl,O=C(c1ccc(CN2CCOCC2)cc1)N1CCN(C2CC2)CC1
3849,CHEMBL3608450,P23975,,XYYAWEJOUNEPTR-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26227772.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET (unknown origin) at 10 uM,,C4 phenyl aporphines with selective h5-HT(2B) receptor affinity.,Bioorg. Med. Chem. Lett.,2015.0,25.0,17.0,"Kapadia N, Harding WW",,1512567.0,DTCT0023180,14522442,DTCC01659060,2010933,63285,50.0,CN1CC(C2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OC)OC)C6=CC=CC=C6,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2c1ccccc1)OCO4
3887,CHEMBL3613642,P23975,,KORKKQLDGMHNKO-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26235950.0,INHIBITION,=,4.0,%,,,,,,,,,,,,,,Binding affinity to human NE transporter assessed as inhibition of control specific binding at 10 uM,,Identification of orally-bioavailable antagonists of the TRPV4 ion-channel.,Bioorg. Med. Chem. Lett.,2015.0,25.0,18.0,"Wei ZL, Nguyen MT, O'Mahony DJ, Acevedo A, Zipfel S, Zhang Q, Liu L, Dourado M, Chi C, Yip V, DeFalco J, Gustafson A, Emerling DE, Kelly MG, Kincaid J, Vincent F, Duncton MA",,1514574.0,DTCT0023180,14536045,DTCC01662099,495991,63547,4.0,CC(C)N1CCN(CC1)S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=C(C=C3)C(F)(F)F)[N+](=O)[O-],CC(C)N1CCN(S(=O)(=O)c2ccc(NC(=O)c3ccc(C(F)(F)F)cc3[N+](=O)[O-])cc2)CC1
3892,CHEMBL3633757,P23975,,AJIMVLSQIMXLNV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26475518.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]-Nisoxetine from recombinant human NET at 10 uM after 1.5 hrs by Microbeta scintillation counting analysis relative to control,,Synthesis and evaluation of aporphine analogs containing C1 allyl isosteres at the h5-HT2A receptor.,Bioorg. Med. Chem. Lett.,2015.0,25.0,22.0,"Ponnala S, Kapadia N, Madapa S, Alberts IL, Harding WW",,1527265.0,DTCT0023180,14599733,DTCC01670761,1077577,64247,50.0,CN1CCC2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OCC6=CC=C(C=C6)Br)OC,COc1cc2c3c(c1OCc1ccc(Br)cc1)-c1cc4c(cc1CC3N(C)CC2)OCO4
3966,CHEMBL366563,P23975,,LEVWYRKDKASIDU-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14727081,DTCC00370225,2103226,69159,10000.0,C(C(C(=O)O)N)SSCC(C(=O)O)N,NC(CSSCC(N)C(=O)O)C(=O)O
4164,CHEMBL3741992,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26460788.0,INHIBITION,<,30.0,%,,,,,,,,,,,,,,Inhibition of human norepinephrine transporter at 10 uM,,Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.,J. Med. Chem.,2015.0,58.0,21.0,"Lopez-Tapia F, Walker KA, Brotherton-Pleiss C, Caroon J, Nitzan D, Lowrie L, Gleason S, Zhao SH, Berger J, Cockayne D, Phippard D, Suttmann R, Fitch WL, Bourdet D, Rege P, Huang X, Broadbent S, Dvorak C, Zhu J, Wagner P, Padilla F, Loe B, Jahangir A, Alker A.",,1541674.0,DTCT0023180,20320,DTCC00065423,1804813,65488,30.0,CC1=CC(=C(C=C1NC(=O)C2=CNC(=O)C[C@H]2C3=CC=C(C=C3)F)OCCO)Cl,Cc1cc(Cl)c(OCCO)cc1NC(=O)C1=CNC(=O)C[C@H]1c1ccc(F)cc1
4201,CHEMBL3763166,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26653033.0,INHIBITION,=,62.0,%,,,,,,,,,,,,,,Inhibition of Norepinephrine transporter (unknown origin) at 10 uM,,"Phenyl Benzenesulfonylhydrazides Exhibit Selective Indoleamine 2,3-Dioxygenase Inhibition with Potent in Vivo Pharmacodynamic Activity and Antitumor Efficacy.",J. Med. Chem.,2016.0,59.0,1.0,"Lin SY, Yeh TK, Kuo CC, Song JS, Cheng MF, Liao FY, Chao MW, Huang HL, Chen YL, Yang CY, Wu MH, Hsieh CL, Hsiao W, Peng YH, Wu JS, Lin LM, Sun M, Chao YS, Shih C, Wu SY, Pan SL, Hung MS, Ueng SH.",,1553781.0,DTCT0023180,91908,DTCC00075195,807224,66086,62.0,C1C2=C(C=CC(=C2)S(=O)(=O)NNC3=CC=C(C=C3)Br)NC1=O,O=C1Cc2cc(S(=O)(=O)NNc3ccc(Br)cc3)ccc2N1
4245,CHEMBL3775436,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26988801.0,INHIBITION,=,52.6,%,,,,,,,,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016.0,24.0,8.0,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559739.0,DTCT0023180,118990,DTCC00081018,517082,66408,52.6,CC1=C(C(=CC=C1)C)OCCOCCN[C@H](C)CO.Cl,Cc1cccc(C)c1OCCOCCN[C@H](C)CO
4254,CHEMBL3775769,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26988801.0,INHIBITION,=,34.5,%,,,,,,,,,,,,,,Displacement of [3H]nisoxentine from human recombinant norepinephrine transporter expressed in CHO cells at 10'-5 M,,"Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.",Bioorg. Med. Chem.,2016.0,24.0,8.0,"Waszkielewicz AM, Gunia-Krzyzak A, Powroznik B, Soczynska K, Pekala E, Walczak M, Bednarski M, Zesawska E, Nitek W, Marona H.",,1559739.0,DTCT0023180,119876,DTCC00081020,774921,66408,34.5,CC1=C(C(=CC=C1)C)OCCOCCN[C@@H](C)CO.Cl,Cc1cccc(C)c1OCCOCCN[C@@H](C)CO
4346,CHEMBL3823832,P23975,,,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,INHIBITION,=,51.0,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant norepinephrine transporter expressed in CHO cells at 10 uM after 120 mins by scintillation counting analysis,,In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents,MedChemComm,2016.0,7.0,6.0,"Shao L, Campbell UC, Fang QK, Powell NA, Campbell JE, Jones PG, Hanania T, Alexandrov V, Morganstern I, Sabath E, Zhong HM, Large TH, Spear KL",,1586715.0,DTCT0023180,303639,DTCC00099681,1722211,67430,51.0,CC1=C(C2=CC=CC=C2S1)[C@@H]3C=CNC=N3,Cc1sc2ccccc2c1[C@@H]1C=CNC=N1
4438,CHEMBL395368,P23975,,ZYALYWXELCWDBL-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17127059.0,KI,=,118.0,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007.0,17.0,4.0,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453471.0,DTCT0023180,2219073,DTCC00477229,67033,24220,118.0,CN1CC(C2=C(C1)C=C(C=C2)OCCCN3CCC(CC3)F)C4=CC=C(C=C4)SC,CSc1ccc(C2CN(C)Cc3cc(OCCCN4CCC(F)CC4)ccc32)cc1
4440,CHEMBL395609,P23975,,DIMAAAZZSSXDEH-DFBJGRDBSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17127059.0,KI,=,121.0,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of [3H]nisoxetine uptake in human NET expressed in MDCK cells,,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2007.0,17.0,4.0,"Letavic MA, Keith JM, Jablonowski JA, Stocking EM, Gomez LA, Ly KS, Miller JM, Barbier AJ, Bonaventure P, Boggs JD, Wilson SJ, Miller KL, Lord B, McAllister HM, Tognarelli DJ, Wu J, Abad MC, Schubert C, Lovenberg TW, Carruthers NI",,453471.0,DTCT0023180,2219074,DTCC00477237,682203,24220,121.0,C[C@H]1COCCN1CCCOC2=CC3=C(C=C2)[C@@H](CN(C3)C)C4=CC=C(C=C4)OC,COc1ccc([C@@H]2CN(C)Cc3cc(OCCCN4CCOC[C@@H]4C)ccc32)cc1
4613,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8496700.0,INHIBITION,>,50.0,%,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake site of norepinephrine transporter at 100 nM,,The role of receptor binding in drug discovery.,J. Nat. Prod.,1993.0,56.0,4.0,"Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH",,486242.0,DTCT0023180,2642507,DTCC00134078,1600020,27415,50.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4614,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,777.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730113,DTCC00134078,2104059,68466,777.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4615,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,2186.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730119,DTCC00134078,2104059,68466,2186.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4616,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,240.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730116,DTCC00134078,2104048,68566,240.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4617,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9871604.0,KD,=,240.0,NM,,,,,,,,,,,,,,Equilibrium dissociation constant (KD) for Competitive binding between [3H]- nisoxatine and the compound at human Norepinephrine transporter,,"Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.",Bioorg. Med. Chem. Lett.,1998.0,8.0,5.0,"Carlier PR, Lo MM, Lo PC, Richelson E, Tatsumi M, Reynolds IJ, Sharma TA",,142806.0,DTCT0023180,582359,DTCC00134078,1597897,3008,240.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4618,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544.0,KI,=,574.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730115,DTCC00134078,2104043,68918,574.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4619,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544.0,KI,=,599.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730114,DTCC00134078,2104043,68918,599.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4620,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845.0,KI,=,1022.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730120,DTCC00134078,2104044,68736,1022.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4621,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16162005.0,KI,=,440.0,NM,,,,,,,,,,,,,,Binding inhibition towards human norepinephrine transporter,,Conformationally restricted homotryptamines. 2. Indole cyclopropylmethylamines as selective serotonin reuptake inhibitors.,J. Med. Chem.,2005.0,48.0,19.0,"Mattson RJ, Catt JD, Denhart DJ, Deskus JA, Ditta JL, Higgins MA, Marcin LR, Sloan CP, Beno BR, Gao Q, Cunningham MA, Mattson GK, Molski TF, Taber MT, Lodge NJ",,320813.0,DTCT0023180,1853293,DTCC00134078,1587007,19894,440.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4622,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16220969.0,KI,=,2000.0,NM,,,,,,,,,,,,,,Inhibition constant against norepinephrine transporter,,Designed multiple ligands. An emerging drug discovery paradigm.,J. Med. Chem.,2005.0,48.0,21.0,"Morphy R, Rankovic Z",,320757.0,DTCT0023180,1844755,DTCC00134078,1586984,19940,2000.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4623,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750359.0,IC50,=,5200.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at NA transporter expressed in HEK293 cells,,"N-(1,2-diphenylethyl)piperazines: a new class of dual serotonin/noradrenaline reuptake inhibitor.",Bioorg. Med. Chem. Lett.,2006.0,16.0,16.0,"Jonathan Fray M, Bish G, Brown AD, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,390293.0,DTCT0023180,1965623,DTCC00134078,1598974,21201,5200.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4624,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16750363.0,IC50,=,5200.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA reuptake at NA transporter in HEK293 cells,,Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2006.0,16.0,16.0,"Fray MJ, Bish G, Fish PV, Stobie A, Wakenhut F, Whitlock GA",,379063.0,DTCT0023180,1964061,DTCC00134078,1587235,21124,5200.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4625,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609.0,INHIBITION,=,1.0,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008.0,51.0,10.0,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281.0,DTCT0023180,2556618,DTCC00134078,1588467,28813,1.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4626,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18550369.0,IC50,=,2000.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of norepinephrine uptake at human NET in human HEK293 cells,,"Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).",Bioorg. Med. Chem. Lett.,2008.0,18.0,14.0,"Wu D, Pontillo J, Ching B, Hudson S, Gao Y, Fleck BA, Gogas K, Wade WS",,491609.0,DTCT0023180,2649861,DTCC00134078,1599701,31203,2000.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4627,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18667309.0,IC50,=,2000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in HEK cells,,Synthesis and structure-activity relationships of selective norepinephrine reuptake inhibitors (sNRI) with a heterocyclic ring constraint.,Bioorg. Med. Chem. Lett.,2008.0,18.0,16.0,"Hudson S, Kiankarimi M, Eccles W, Mostofi YS, Genicot MJ, Dwight W, Fleck BA, Gogas K, Wade WS",,510054.0,DTCT0023180,2445668,DTCC00134078,1588704,30880,2000.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4628,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916.0,IC50,=,563.0,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008.0,18.0,18.0,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516.0,DTCT0023180,2686033,DTCC00134078,1600087,31294,563.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4629,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888.0,IC50,=,1020.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NE from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009.0,17.0,1.0,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560772.0,DTCT0023180,2467266,DTCC00134078,1588359,31698,1020.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4630,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19014888.0,KI,=,1560.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI55 from human recombinant NET expressed in HEK293 cells,,Stereoselective inhibition of serotonin re-uptake and phosphodiesterase by dual inhibitors as potential agents for depression.,Bioorg. Med. Chem.,2009.0,17.0,1.0,"Cashman JR, Voelker T, Johnson R, Janowsky A",,560769.0,DTCT0023180,2467242,DTCC00134078,1588359,31698,1560.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4631,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502.0,IC50,=,1020.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [3H]norepinephrine from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009.0,52.0,6.0,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543533.0,DTCT0023180,2809682,DTCC00134078,1588201,32805,1020.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4632,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19256502.0,KI,=,1560.0,NM,,cell_based,,,,,,,,,,,HEK293,Displacement of [125I]RTI-55 from human recombinant NET expressed in HEK293 cells by scintillation counting,,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,2009.0,52.0,6.0,"Cashman JR, Voelker T, Zhang HT, O'Donnell JM",,543530.0,DTCT0023180,2809655,DTCC00134078,1588201,32805,1560.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4633,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313.0,IC50,=,563.0,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009.0,19.0,9.0,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244.0,DTCT0023180,2725270,DTCC00134078,1588425,34196,563.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4634,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20724153.0,IC50,,,,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine reuptake at human NET expressed in MDCK cells,Not Determined,Synthesis and pharmacological evaluation of 3-aryl-3-azolylpropan-1-amines as selective triple serotonin/norepinephrine/dopamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010.0,20.0,18.0,"Lee KH, Park CE, Min KH, Shin YJ, Chung CM, Kim HH, Yoon HJ, Won-Kim , Ryu EJ, Shin YJ, Nam HS, Cho JW, Lee HY",,654118.0,DTCT0023180,3446705,DTCC00134078,1601490,40497,,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4635,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,IC50,=,6309.57,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465491,DTCC00134078,1612408,54821,6309.57,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4636,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,KI,=,1394.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465490,DTCC00134078,1612408,54821,1394.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4637,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181.0,INHIBITION,=,56.0,%,,cell_based,,,,,,,,,,,HEK293,Inhibition of human NET-mediated norepinephrine uptake expressed in HEK293 cells at 10 uM after 15 mins by fluorescence plate reader analysis,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013.0,23.0,20.0,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983930.0,DTCT0023180,12598171,DTCC00134078,1612570,55968,56.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4638,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340.0,IC50,=,4410.0,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014.0,24.0,15.0,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455467.0,DTCT0023180,13880514,DTCC00134078,1593183,60843,4410.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4639,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340.0,INHIBITION,=,5.0,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014.0,24.0,15.0,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1454672.0,DTCT0023180,13876492,DTCC00134078,1593183,60843,5.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4640,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340.0,INHIBITION,=,8.0,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 1 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014.0,24.0,15.0,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455479.0,DTCT0023180,13885100,DTCC00134078,1593183,60843,8.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4641,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24974340.0,INHIBITION,=,56.0,%,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in HEK293 cells at 10 uM after 15 mins by fluorescence neurotransmitter transporter assay,,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2014.0,24.0,15.0,"Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG",,1455483.0,DTCT0023180,13880734,DTCC00134078,1593183,60843,56.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4642,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1303.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7322665,DTCC00134078,1609546,46191,1303.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4643,CHEMBL41,P23975,FLUOXETINE,RTHCYVBBDHJXIQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1292.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7322666,DTCC00134078,1609546,46191,1292.0,CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F,CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1
4682,CHEMBL41543,P23975,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7291805,DTCC00180007,866015,46191,,C1CC2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N,NC(=O)N1c2ccccc2CCc2ccccc21
4683,CHEMBL41543,P23975,,PHNLCHMJDSSPDQ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7291806,DTCC00180007,866015,46191,,C1CC2=CC=CC=C2N(C3=CC=CC=C31)C(=O)N,NC(=O)N1c2ccccc2CCc2ccccc21
4702,CHEMBL42,P23975,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1470.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7363107,DTCC00134115,51460,46191,1470.0,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
4703,CHEMBL42,P23975,CLOZAPINE,QZUDBNBUXVUHMW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1458.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7363108,DTCC00134115,51460,46191,1458.0,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
4772,CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12761331.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14730557,DTCC00186878,2104160,68767,10000.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
4773,CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19717215.0,IC50,=,405.0,NM,,,,,,,,,,,,,,Inhibition of human noradrenaline transporter,,Synthesis and serotonin transporter activity of sulphur-substituted alpha-alkyl phenethylamines as a new class of anticancer agents.,Eur. J. Med. Chem.,2009.0,44.0,12.0,"Cloonan SM, Keating JJ, Butler SG, Knox AJ, Jørgensen AM, Peters GH, Rai D, Corrigan D, Lloyd DG, Williams DC, Meegan MJ",,622530.0,DTCT0023180,3256937,DTCC00186878,295616,37648,405.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
4774,CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20466553.0,IC50,=,405.0,NM,,,,,,,,,,,,,,Binding affinity to human NET,,"Synthesis and in vitro toxicity of 4-MTA, its characteristic clandestine synthesis byproducts and related sulfur substituted alpha-alkylthioamphetamines.",Bioorg. Med. Chem.,2010.0,18.0,11.0,"Cloonan SM, Keating JJ, Corrigan D, O'Brien JE, Kavanagh PV, Williams DC, Meegan MJ",,639476.0,DTCT0023180,3376847,DTCC00186878,307550,39293,405.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
4775,CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,IC50,=,1995.26,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465487,DTCC00186878,318410,54821,1995.26,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
4776,CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23602445.0,KI,=,398.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells preincubated for 10 mins prior to substrate addition measured after 4 mins by FLIPR assay,,An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.,Bioorg. Med. Chem. Lett.,2013.0,23.0,11.0,"Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S",,965140.0,DTCT0023180,12465486,DTCC00186878,318410,54821,398.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
4777,CHEMBL43048,P23975,METHYLENEDIOXYMETHAMPHETAMINE,SHXWCVYOXRDMCX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,26233799.0,EC50,=,1000.0,NM,,cell_based,,,,,,,,,,,,Binding affinity to human NET expressed in HEK293 cells assessed as induction of [3H]MPP+ release by liquid scintillation counting method,,"Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine.",Bioorg. Med. Chem.,2015.0,23.0,17.0,"Del Bello F, Sakloth F, Partilla JS, Baumann MH, Glennon RA",,1511143.0,DTCT0023180,14500361,DTCC00186878,288908,63351,1000.0,CC(CC1=CC2=C(C=C1)OCO2)NC,CNC(C)Cc1ccc2c(c1)OCO2
4861,CHEMBL444985,P23975,,ZINGRQZUIVEPKX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174.0,IC50,=,4400.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009.0,19.0,8.0,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828.0,DTCT0023180,2620113,DTCC00570244,586439,33285,4400.0,C1CNCCC1COC2=CC3=C(C=CC(=C3)C#N)C=C2,N#Cc1ccc2ccc(OCC3CCNCC3)cc2c1
4976,CHEMBL453996,P23975,,MUOXAGUZMVATIC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174.0,IC50,=,1800.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009.0,19.0,8.0,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828.0,DTCT0023180,2620105,DTCC00570174,1653671,33285,1800.0,C1CNCCC1COC2=CC3=CC=CC=C3C=C2,c1ccc2cc(OCC3CCNCC3)ccc2c1
5048,CHEMBL459730,P23975,,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18754613.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]nisoxetine from human cloned NET,,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,2008.0,51.0,18.0,"Donohue SR, Pike VW, Finnema SJ, Truong P, Andersson J, Gulyás B, Halldin C",,512536.0,DTCT0023180,2562884,DTCC00529017,2036926,31906,50.0,C1[C@@H](C(=NN1/C(=N/S(=O)(=O)C2=CC=C(C=C2)C#N)/N)C3=CC=C(C=C3)Cl)C4=CC=CC=C4,N#Cc1ccc(S(=O)(=O)/N=C(\N)N2C[C@H](c3ccccc3)C(c3ccc(Cl)cc3)=N2)cc1
5051,CHEMBL46,P23975,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7401674,DTCC00134875,315668,46191,,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O
5052,CHEMBL46,P23975,ONDANSETRON,FELGMEQIXOGIFQ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7401675,DTCC00134875,315668,46191,,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O
5105,CHEMBL464099,P23975,N-METHYLLAUROTETANINE,ZFLRVRLYWHNAEC-AWEZNQCLSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25695425.0,KI,>,950.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human recombinant NET expressed in HEK cell membranes by radioligand binding assay,,Semisynthetic Studies on and Biological Evaluation of N-Methyllaurotetanine Analogues as Ligands for 5-HT Receptors.,J. Nat. Prod.,2015.0,78.0,4.0,"Madapa S, Harding WW",,1499799.0,DTCT0023180,14439266,DTCC00005857,624816,62678,950.0,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC(=C(C=C43)OC)O)OC)OC,COc1cc2c(cc1O)C[C@H]1c3c(cc(OC)c(OC)c3-2)CCN1C
5124,CHEMBL467094,P23975,NANTENINE,WSVWKHTVFGTTKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19963380.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human NET,,Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.,Bioorg. Med. Chem. Lett.,2010.0,20.0,2.0,"Legendre O, Pecic S, Chaudhary S, Zimmerman SM, Fantegrossi WE, Harding WW",,604293.0,DTCT0023180,3169950,DTCC00115128,663129,36881,10000.0,CN1CCC2=CC(=C(C3=C2C1CC4=CC5=C(C=C43)OCO5)OC)OC,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4
5199,CHEMBL471035,P23975,,IMESNXOOQNBNMN-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19282174.0,IC50,=,827.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of radiolabeled noradrenaline reuptake at human NET expressed in HEK293 cells,,Design and optimization of selective serotonin re-uptake inhibitors with high synthetic accessibility. Part 1.,Bioorg. Med. Chem. Lett.,2009.0,19.0,8.0,"Andrews M, Brown A, Chiva JY, Fradet D, Gordon D, Lansdell M, MacKenny M",,564828.0,DTCT0023180,2620117,DTCC00570245,2004653,33285,827.0,COCC(C1CCNCC1)OC2=CC3=CC=CC=C3C=C2,COCC(Oc1ccc2ccccc2c1)C1CCNCC1
5227,CHEMBL475965,P23975,,IFWGJAXMPXZADJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19146417.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"The discovery of a selective, small molecule agonist for the MAS-related gene X1 receptor.",J. Med. Chem.,2009.0,52.0,3.0,"Wroblowski B, Wigglesworth MJ, Szekeres PG, Smith GD, Rahman SS, Nicholson NH, Muir AI, Hall A, Heer JP, Garland SL, Coates WJ",,516839.0,DTCT0023180,2696311,DTCC00550152,1567645,32399,10.0,CC1=C(C=CC=C1NC(=O)C2=CC=C(C=C2)C3=CN=C(C=C3)OC)CN4C(=O)C=C(C=N4)N5CCNCC5,COc1ccc(-c2ccc(C(=O)Nc3cccc(Cn4ncc(N5CCNCC5)cc4=O)c3C)cc2)cn1
5271,CHEMBL479,P23975,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1551.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7459371,DTCC00137035,185558,46191,1551.0,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
5272,CHEMBL479,P23975,THIORIDAZINE,KLBQZWRITKRQQV-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1538.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7459372,DTCC00137035,185558,46191,1538.0,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
5274,CHEMBL479383,P23975,,IJHSPFFWIXGDBB-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488400.0,DTCT0023180,2775972,DTCC00525641,1756334,30579,10.0,C1CN(CCC1NC(=O)CO)CC2=CC=C(C=C2)OC3=NC4=CC=CC=C4S3,O=C(CO)NC1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1
5279,CHEMBL479683,P23975,,OLLHYYCQHNBTQC-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24582985.0,INHIBITION,=,34.6,%,,,,,,,,,,,,,,Inhibition of NET (unknown origin) at 10 uM by radioligand binding assay relative to control,,5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC): a novel non-nitrogenous ligand for 5-HT2B receptor.,Bioorg. Med. Chem. Lett.,2014.0,24.0,6.0,"Williams DA, Zaidi SA, Zhang Y",,1296934.0,DTCT0023180,13068439,DTCC00537969,1127642,57600,34.6,C1=CC=C(C=C1)CCC2=CC(=O)C3=C(C=CC=C3O2)O,O=c1cc(CCc2ccccc2)oc2cccc(O)c12
5289,CHEMBL481280,P23975,,BUZBVOKDNAZIIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488400.0,DTCT0023180,2775946,DTCC00525642,1756335,30579,10.0,C1CN(CCC1C(=O)O)CC2=CC=C(C=C2)OC3=NC4=CC=CC=C4S3,O=C(O)C1CCN(Cc2ccc(Oc3nc4ccccc4s3)cc2)CC1
5297,CHEMBL481863,P23975,JNJ-10392980,ZIQGASWXUSSORV-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18588282.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of human NET at 1 uM,,"Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.",J. Med. Chem.,2008.0,51.0,14.0,"Grice CA, Tays KL, Savall BM, Wei J, Butler CR, Axe FU, Bembenek SD, Fourie AM, Dunford PJ, Lundeen K, Coles F, Xue X, Riley JP, Williams KN, Karlsson L, Edwards JP",,488400.0,DTCT0023180,2775894,DTCC00006309,207957,30579,10.0,C1CCN(CC1)CCOC2=CC=C(C=C2)OC3=NC4=CC=CC=C4O3,c1ccc2oc(Oc3ccc(OCCN4CCCCC4)cc3)nc2c1
5305,CHEMBL483749,P23975,,QPUXUSUONDVIKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19338356.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009.0,52.0,7.0,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497700.0,DTCT0023180,2728014,DTCC00569050,273669,34004,50.0,C1CCC(CC1)C2=NC3=C(C=CC(=C3)C(=O)NN4CCCCC4)SC5=CC=CC=C52,O=C(NN1CCCCC1)c1ccc2c(c1)N=C(C1CCCCC1)c1ccccc1S2
5308,CHEMBL484952,P23975,,MTEFLXYKMHWTNG-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19338356.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009.0,52.0,7.0,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497700.0,DTCT0023180,2728015,DTCC00569111,759316,34004,50.0,CCCCNC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3C(=N2)C4=CC=C(C=C4)Cl,CCCCNC(=O)c1ccc2c(c1)N=C(c1ccc(Cl)cc1)c1ccccc1S2
5354,CHEMBL49,P23975,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7263300,DTCC00135177,120970,46191,,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
5355,CHEMBL49,P23975,BUSPIRONE,QWCRAEMEVRGPNT-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7263301,DTCC00135177,120970,46191,,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1
5472,CHEMBL50,P23975,QUERCETIN,REFJWTPEDVJJIY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14729957,DTCC00135230,2104025,69275,10000.0,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12
5473,CHEMBL500,P23975,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7385197,DTCC00139321,736265,46191,,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,CC(C)NCC(O)COc1cccc2[nH]ccc12
5474,CHEMBL500,P23975,PINDOLOL,JZQKKSLKJUAGIC-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7385198,DTCC00139321,736265,46191,,CC(C)NCC(COC1=CC=CC2=C1C=CN2)O,CC(C)NCC(O)COc1cccc2[nH]ccc12
5643,CHEMBL519240,P23975,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18983139.0,ACTIVITY,=,88.6,%,,,,,,,,,,,,,,Binding affinity to human NET at 10 uM relative to control,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008.0,51.0,22.0,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494421.0,DTCT0023180,2604340,DTCC00008943,1621329,32034,88.6,C1CC[C@H]2[C@@H](C1)C3=C(O2)CCC4=C3N=C(N=C4N5CCNCC5)N,Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
5644,CHEMBL519240,P23975,A-987306,DJKJVWJQAVGLHJ-YPMHNXCESA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18983139.0,INHIBITION,=,11.0,%,,,,,,,,,,,,,,Inhibition of human NET at 10 uM,,"cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.",J. Med. Chem.,2008.0,51.0,22.0,"Liu H, Altenbach RJ, Carr TL, Chandran P, Hsieh GC, Lewis LG, Manelli AM, Milicic I, Marsh KC, Miller TR, Strakhova MI, Vortherms TA, Wakefield BD, Wetter JM, Witte DG, Honore P, Esbenshade TA, Brioni JD, Cowart MD",,494203.0,DTCT0023180,2604260,DTCC00008943,1621329,32034,11.0,C1CC[C@H]2[C@@H](C1)C3=C(O2)CCC4=C3N=C(N=C4N5CCNCC5)N,Nc1nc2c(c(N3CCNCC3)n1)CCC1=C2[C@@H]2CCCC[C@@H]2O1
5650,CHEMBL520349,P23975,,OHOQFGDSEWQDAX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19338356.0,ACTIVITY,<,50.0,%,,,,,,,,,,,,,,Binding affinity to NET,Active,Synthesis and evaluation of dibenzothiazepines: a novel class of selective cannabinoid-1 receptor inverse agonists.,J. Med. Chem.,2009.0,52.0,7.0,"Pettersson H, Bülow A, Ek F, Jensen J, Ottesen LK, Fejzic A, Ma JN, Del Tredici AL, Currier EA, Gardell LR, Tabatabaei A, Craig D, McFarland K, Ott TR, Piu F, Burstein ES, Olsson R",,497700.0,DTCT0023180,2728016,DTCC00569166,1178835,34004,50.0,CCCCNC(=O)C1=CC2=C(C=C1)SC3=CC=CC=C3C(=N2)C4=CC(=C(C=C4)F)Cl,CCCCNC(=O)c1ccc2c(c1)N=C(c1ccc(F)c(Cl)c1)c1ccccc1S2
5743,CHEMBL54,P23975,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,25070422.0,KI,=,5500.0,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human Norepinephrine transporter by liquid scintillation counting,,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,2014.0,24.0,17.0,"Sampson D, Bricker B, Zhu XY, Peprah K, Lamango NS, Setola V, Roth BL, Ablordeppey SY",,1452255.0,DTCT0023180,13943039,DTCC00135385,59464,61087,5500.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
5744,CHEMBL54,P23975,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1836.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7334065,DTCC00135385,51476,46191,1836.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
5745,CHEMBL54,P23975,HALOPERIDOL,LNEPOXFFQSENCJ-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1820.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7334066,DTCC00135385,51476,46191,1820.0,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
5779,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,7865.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732365,DTCC00144121,2104667,68466,7865.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5780,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732373,DTCC00144121,2104667,68466,10000.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5781,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,4070.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732372,DTCC00144121,2104657,68566,4070.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5782,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,11454918.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732374,DTCC00144121,2104466,69315,10000.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5783,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544.0,KI,=,5029.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732369,DTCC00144121,2104459,68918,5029.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5784,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544.0,KI,=,6190.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732368,DTCC00144121,2104459,68918,6190.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5785,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544.0,KI,=,6514.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732367,DTCC00144121,2104459,68918,6514.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5786,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12232544.0,KI,=,7841.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732366,DTCC00144121,2104459,68918,7841.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5787,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476.0,KI,=,4870.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732371,DTCC00144121,2104658,69177,4870.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5788,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14744476.0,KI,=,8690.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732364,DTCC00144121,2104658,69177,8690.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5789,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14971892.0,KI,=,6190.0,NM,,,,,,,,,,,,,,In vitro binding affinity against human norepinephrine transporter in human embryonic kidney cell line by using [3H]-nisoxatine radioligand,,"Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter.",J. Med. Chem.,2004.0,47.0,5.0,"Plisson C, McConathy J, Martarello L, Malveaux EJ, Camp VM, Williams L, Votaw JR, Goodman MM",,144969.0,DTCT0023180,936948,DTCC00144121,435920,17996,6190.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5790,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18429609.0,INHIBITION,=,0.24,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine reuptake at human NET expressed in african green monkey COS7 cells at 100 nM,,From the selective serotonin transporter inhibitor citalopram to the selective norepinephrine transporter inhibitor talopram: synthesis and structure-activity relationship studies.,J. Med. Chem.,2008.0,51.0,10.0,"Eildal JN, Andersen J, Kristensen AS, Jørgensen AM, Bang-Andersen B, Jørgensen M, Strømgaard K",,556281.0,DTCT0023180,2556602,DTCC00144121,425329,28813,0.24,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5791,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23168018.0,KI,>,1000000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]dopamine uptake at human NET expressed in COS7 cells after 5 mins by beta-counting,,A rhodamine-labeled citalopram analogue as a high-affinity fluorescent probe for the serotonin transporter.,Bioorg. Med. Chem. Lett.,2013.0,23.0,1.0,"Zhang P, Jørgensen TN, Loland CJ, Newman AH",,943964.0,DTCT0023180,11814469,DTCC00144121,428618,53759,1000000.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5792,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,2196.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7351962,DTCC00144121,444637,46191,2196.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5793,CHEMBL549,P23975,CITALOPRAM,WSEQXVZVJXJVFP-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,2178.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7351963,DTCC00144121,444637,46191,2178.0,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F,CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21
5794,CHEMBL54943,P23975,CYSTEINE,XUJNEKJLAYXESH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12649361.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14732636,DTCC00201307,2103464,69159,10000.0,C(C(C(=O)O)N)S,NC(CS)C(=O)O
5840,CHEMBL555146,P23975,,VGSYEFOBFMUWGO-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22313227.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant NET,,Radiosynthesis and evaluation of an (18)F-labeled positron emission tomography (PET) radioligand for brain histamine subtype-3 receptors based on a nonimidazole 2-aminoethylbenzofuran chemotype.,J. Med. Chem.,2012.0,55.0,5.0,"Bao X, Lu S, Liow JS, Zoghbi SS, Jenko KJ, Clark DT, Gladding RL, Innis RB, Pike VW",,818831.0,DTCT0023180,10474292,DTCC00380469,1106159,48153,10000.0,C[C@@H]1CCCN1CCC2=CC3=C(O2)C=CC(=C3)C(=O)C4=CC=C(C=C4)F,C[C@@H]1CCCN1CCc1cc2cc(C(=O)c3ccc(F)cc3)ccc2o1
5874,CHEMBL559456,P23975,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175.0,IC50,=,6.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009.0,19.0,10.0,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205.0,DTCT0023180,2876628,DTCC00582984,339382,34589,6.0,C1CNCCC1C(C2=CN=CC=C2)OC3=C(C(=CC=C3)Cl)Cl,Clc1cccc(OC(c2cccnc2)C2CCNCC2)c1Cl
5875,CHEMBL559456,P23975,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175.0,IC50,=,7.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009.0,19.0,10.0,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205.0,DTCT0023180,2876612,DTCC00582984,339381,34589,7.0,C1CNCCC1C(C2=CN=CC=C2)OC3=C(C(=CC=C3)Cl)Cl,Clc1cccc(OC(c2cccnc2)C2CCNCC2)c1Cl
5876,CHEMBL559456,P23975,,NTBRVAZZXJHBGJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19359175.0,IC50,=,128.0,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]NA uptake at human NET expressed in HEK293 cells,,"4-Piperidines and 3-pyrrolidines as dual serotonin and noradrenaline reuptake inhibitors: design, synthesis and structure-activity relationships.",Bioorg. Med. Chem. Lett.,2009.0,19.0,10.0,"Fish PV, Andrews MD, Jonathan Fray M, Stobie A, Wakenhut F, Whitlock GA",,575205.0,DTCT0023180,2876629,DTCC00582984,339383,34589,128.0,C1CNCCC1C(C2=CN=CC=C2)OC3=C(C(=CC=C3)Cl)Cl,Clc1cccc(OC(c2cccnc2)C2CCNCC2)c1Cl
5974,CHEMBL56564,P23975,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7453745,DTCC00204705,736266,46191,,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,CN1[C@H]2CC[C@@H]1CC(OC(=O)c1c[nH]c3ccccc13)C2
5975,CHEMBL56564,P23975,TROPISETRON,ZNRGQMMCGHDTEI-ITGUQSILSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7453746,DTCC00204705,736266,46191,,CN1[C@@H]2CC[C@H]1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,CN1[C@H]2CC[C@@H]1CC(OC(=O)c1c[nH]c3ccccc13)C2
6066,CHEMBL569270,P23975,,UTPGRZGMQVAYAA-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24147864.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to human NET by PDSP assay,,Synthesis and evaluation in monkey of [(18)F]4-fluoro-N-methyl-N-(4-(6-(methylamino)pyrimidin-4-yl)thiazol-2-yl)benzamide ([(18)F]FIMX): a promising radioligand for PET imaging of brain metabotropic glutamate receptor 1 (mGluR1).,J. Med. Chem.,2013.0,56.0,22.0,"Xu R, Zanotti-Fregonara P, Zoghbi SS, Gladding RL, Woock AE, Innis RB, Pike VW",,1274768.0,DTCT0023180,12941169,DTCC00606473,1333771,56413,10000.0,CNC1=NC=NC(=C1)C2=CSC(=N2)N(C)C(=O)C3=CC=C(C=C3)F,CNc1cc(-c2csc(N(C)C(=O)c3ccc(F)cc3)n2)ncn1
6231,CHEMBL590615,P23975,,CWYDYWFZPBTTIM-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to NET,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603566.0,DTCT0023180,3164455,DTCC00609878,176896,36082,10000.0,C1C2C3C4C1C5C2C6C3C4C5(O6)NCCC7=CC(=CC=C7)F,Fc1cccc(CCNC23OC4C5C6CC(C7C6C4C72)C53)c1
6266,CHEMBL595449,P23975,,ILPANLYEJQKXKY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19646882.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of NET,,Novel delta opioid receptor agonists exhibit differential stimulation of signaling pathways.,Bioorg. Med. Chem.,2009.0,17.0,17.0,"Peng Y, Zhang Q, Arora S, Keenan SM, Kortagere S, Wannemacher KM, Howells RD, Welsh WJ",,601720.0,DTCT0023180,3163186,DTCC00612138,1136637,36541,10000.0,CC(C)(C)C1=CC=C(C=C1)C2=NC(=NN2C3=CC(=CC=C3)O)CN(C)C,CN(C)Cc1nc(-c2ccc(C(C)(C)C)cc2)n(-c2cccc(O)c2)n1
6350,CHEMBL599760,P23975,RO-85,WLMBSKSEPQCRJV-OAHLLOKOSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20045645.0,ACTIVITY,>,50.0,%,,cell_based,,,,,,,,,,,CHO,Displacement of [3H]nisoxetine from human recombinant NET expressed in CHO cells at 10 uM after 120 mins by scintillation counting,,"Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.",Bioorg. Med. Chem. Lett.,2010.0,20.0,3.0,"Brotherton-Pleiss CE, Dillon MP, Ford AP, Gever JR, Carter DS, Gleason SK, Lin CJ, Moore AG, Thompson AW, Villa M, Zhai Y",,612708.0,DTCT0023180,3188590,DTCC00030157,1918622,37451,50.0,C[C@H](CN1CCN(CC1)C(=O)C)NC(=O)C2=CC3=C(S2)N(N=C3C4=CC=CC=C4)C,CC(=O)N1CCN(C[C@@H](C)NC(=O)c2cc3c(-c4ccccc4)nn(C)c3s2)CC1
6359,CHEMBL600053,P23975,,BKYSPAJPVPEZOE-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NET at 10 uM,,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603565.0,DTCT0023180,3164454,DTCC00609877,405425,36082,50.0,C1C2C3C4C1C5C2C6C3C4C5(O6)NCC7=CC(=CC=C7)F,Fc1cccc(CNC23OC4C5C6CC(C7C6C4C72)C53)c1
6376,CHEMBL602850,P23975,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603565.0,DTCT0023180,3164453,DTCC00609826,1309981,36082,,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccc(F)c1
6377,CHEMBL602850,P23975,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11474342,DTCC00609826,1300183,51935,,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccc(F)c1
6378,CHEMBL602850,P23975,,FYGREZKTJIXWIH-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12600276,DTCC00609826,1301031,55935,,C1C2C3C4C1C5C2C6C3C4C5(N6CCC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2CCc1cccc(F)c1
6426,CHEMBL608560,P23975,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19954972.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of NET at 10 uM,Not Determined,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,2010.0,20.0,1.0,"Banister SD, Moussa IA, Jordan MJ, Coster MJ, Kassiou M",,603565.0,DTCT0023180,3164343,DTCC00609825,1789660,36082,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccc(F)c1
6427,CHEMBL608560,P23975,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to NET,Not Determined,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,2012.0,22.0,19.0,"Banister SD, Manoli M, Doddareddy MR, Hibbs DE, Kassiou M",,884098.0,DTCT0023180,11474370,DTCC00609825,1780158,51935,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccc(F)c1
6428,CHEMBL608560,P23975,,DUZFRLZTNIIHKJ-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23981939.0,KI,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]-nisoxetine from human NET expressed in HEK cell membranes,Not Determined,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,2013.0,21.0,19.0,"Banister SD, Manoli M, Barron ML, Werry EL, Kassiou M",,985449.0,DTCT0023180,12600278,DTCC00609825,1780917,55935,,C1C2C3C4C1C5C2C6C3C4C5(N6CC7=CC(=CC=C7)F)O,OC12C3C4CC5C6C4C1C6C(C53)N2Cc1cccc(F)c1
6509,CHEMBL63354,P23975,AMENTOFLAVONE,YUSWMAULDXZHPY-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12110997.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14753800,DTCC00216407,2103540,69275,10000.0,C1=CC(=CC=C1C2=CC(=O)C3=C(O2)C(=C(C=C3O)O)C4=C(C=CC(=C4)C5=CC(=O)C6=C(C=C(C=C6O5)O)O)O)O,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12
6561,CHEMBL6437,P23975,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,163.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7409115,DTCC00132673,1383778,46191,163.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,CN1CCN2c3ccccc3Cc3ccccc3C2C1
6562,CHEMBL6437,P23975,MIANSERIN,UEQUQVLFIPOEMF-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,161.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7409116,DTCC00132673,1383778,46191,161.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=CC=CC=C42,CN1CCN2c3ccccc3Cc3ccccc3C2C1
6563,CHEMBL644,P23975,TRIMIPRAMINE,ZSCDBOWYZJWBIY-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,2450.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14746486,DTCC00154839,2109191,68566,2450.0,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C,CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
6580,CHEMBL654,P23975,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,2900.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738875,DTCC00155023,2106815,68566,2900.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CN1CCN2c3ncccc3Cc3ccccc3C2C1
6581,CHEMBL654,P23975,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,4600.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14747115,DTCC00155023,2106815,68566,4600.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CN1CCN2c3ncccc3Cc3ccccc3C2C1
6582,CHEMBL654,P23975,MIRTAZAPINE,RONZAEMNMFQXRA-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14738876,DTCC00155023,2106815,68566,10000.0,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CN1CCN2c3ncccc3Cc3ccccc3C2C1
6667,CHEMBL715,P23975,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7393050,DTCC00160346,1512814,46191,,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
6668,CHEMBL715,P23975,OLANZAPINE,KVWDHTXUZHCGIO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7393051,DTCC00160346,1512814,46191,,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
6669,CHEMBL716,P23975,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7400900,DTCC00160380,1734062,46191,,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
6670,CHEMBL716,P23975,QUETIAPINE,URKOMYMAXPYINW-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7400901,DTCC00160380,1734062,46191,,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
6675,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8496700.0,ACTIVITY,=,87.0,%,,,,,,,,,,,,,,Displacement of [3H]DMI from norepinephrine transporter assessed as specific binding relative to total binding,,The role of receptor binding in drug discovery.,J. Nat. Prod.,1993.0,56.0,4.0,"Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH",,486225.0,DTCT0023180,2642478,DTCC00137288,1115064,27415,87.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6676,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,8496700.0,KI,=,580.0,NM,,,,,,,,,,,,,,Displacement of [3H]DMI from norepinephrine transporter,,The role of receptor binding in drug discovery.,J. Nat. Prod.,1993.0,56.0,4.0,"Sweetnam PM, Caldwell L, Lancaster J, Bauer C, McMillan B, Kinnier WJ, Price CH",,486188.0,DTCT0023180,2642477,DTCC00137288,1115064,27415,580.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6677,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,0.63,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715277,DTCC00137288,2099998,68466,0.63,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6678,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9400006.0,KI,=,3.5,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715246,DTCC00137288,2099998,68466,3.5,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6679,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,9537821.0,KI,=,0.83,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715278,DTCC00137288,2099983,68566,0.83,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6680,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,10411589.0,KI,=,8.54,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715219,DTCC00137288,2099987,69057,8.54,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6681,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,12431845.0,KI,=,3.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715228,DTCC00137288,2099985,68736,3.8,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6682,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,14573386.0,KI,=,3.8,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715224,DTCC00137288,2099984,69056,3.8,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6683,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639.0,KI,=,2.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715270,DTCC00137288,2100016,69000,2.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6684,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639.0,KI,=,3.9,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715222,DTCC00137288,2100016,69000,3.9,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6685,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16675639.0,KI,=,4.1,NM,,,,,,,,,,,,,,,,,,,,,,,,DTCT0023180,14715221,DTCC00137288,2100016,69000,4.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6686,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,16989524.0,IC50,=,0.93,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI-55 from human NET expressed in MDCK cell membrane,,Antidepressant principles of the roots of Polygala tenuifolia.,J. Nat. Prod.,2006.0,69.0,9.0,"Cheng MC, Li CY, Ko HC, Ko FN, Lin YL, Wu TS",,526495.0,DTCT0023180,2737610,DTCC00137288,1114709,29650,0.93,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6687,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17123820.0,KI,=,1.0,NM,,,,,,,,,,,,,,Binding affinity at NET,,Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.,Bioorg. Med. Chem.,2007.0,15.0,2.0,"Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C",,432854.0,DTCT0023180,2059434,DTCC00137288,1102696,22425,1.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6688,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17428804.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of [3H]NE uptake at human wild type NET expressed in african green monkey COS1 cells after 48 hrs,Active,chi-Conotoxin and tricyclic antidepressant interactions at the norepinephrine transporter define a new transporter model.,J. Biol. Chem.,2007.0,282.0,24.0,"Paczkowski FA, Sharpe IA, Dutertre S, Lewis RJ",,505500.0,DTCT0023180,2401654,DTCC00137288,1115315,29252,,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6689,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,17846138.0,IC50,=,4.2,NM,,cell_based,,,,,,,,,,,HEK293,Inhibition of [3H]norepinephrine uptake at human NET expressed in HEK293 cells,,"Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.",Antimicrob. Agents Chemother.,2007.0,51.0,11.0,"Kelly JX, Smilkstein MJ, Cooper RA, Lane KD, Johnson RA, Janowsky A, Dodean RA, Hinrichs DJ, Winter R, Riscoe M",,499923.0,DTCT0023180,2718429,DTCC00137288,1103470,34126,4.2,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6690,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008.0,51.0,13.0,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487422.0,DTCT0023180,2657231,DTCC00137288,1103354,30478,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6691,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18557608.0,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human norepinephrine transporter expressed in MDCK-Net6 cells,,Structure-activity relationships of the cycloalkanol ethylamine scaffold: discovery of selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2008.0,51.0,13.0,"Mahaney PE, Gavrin LK, Trybulski EJ, Stack GP, Vu TA, Cohn ST, Ye F, Belardi JK, Santilli AA, Sabatucci JP, Leiter J, Johnston GH, Bray JA, Burroughs KD, Cosmi SA, Leventhal L, Koury EJ, Zhang Y, Mugford CA, Ho DM, Rosenzweig-Lipson SJ, Platt B, Smith VA, Deecher DC",,487421.0,DTCT0023180,2657289,DTCC00137288,1103354,30478,2.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6692,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18771916.0,IC50,=,3.9,NM,,cell_based,,,,,,,,,,,MDCK,Inhibition of norepinephrine uptake at human NET expressed in MDCK cells,,Synthesis and activity of 1-(3-amino-1-phenylpropyl)indolin-2-ones: a new class of selective norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2008.0,18.0,18.0,"McComas CC, Vu AT, Mahaney PE, Cohn ST, Fensome A, Marella MA, Nogle L, Trybulski EJ, Ye F, Zhang P, Alfinito P, Bray J, Johnston G, Koury E, Deecher DC",,535516.0,DTCT0023180,2686097,DTCC00137288,1115150,31294,3.9,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6693,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,18951020.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,"Synthesis and activity of novel 1- or 3-(3-amino-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones as selective norepinephrine reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2008.0,18.0,23.0,"Zhang P, Terefenko EA, McComas CC, Mahaney PE, Vu A, Trybulski E, Koury E, Johnston G, Bray J, Deecher D",,558178.0,DTCT0023180,2789686,DTCC00137288,1103398,31613,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6694,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19329313.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,3-(Arylamino)-3-phenylpropan-2-olamines as a new series of dual norepinephrine and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009.0,19.0,9.0,"Vu AT, Cohn ST, Terefenko EA, Moore WJ, Zhang P, Mahaney PE, Trybulski EJ, Goljer I, Dooley R, Bray JA, Johnston GH, Leiter J, Deecher DC",,500244.0,DTCT0023180,2725363,DTCC00137288,1103637,34196,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6695,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19632110.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine reuptake at human NET expressed in MDCK-Net6 cells,,"Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.",Bioorg. Med. Chem. Lett.,2009.0,19.0,17.0,"Kim CY, Mahaney PE, McConnell O, Zhang Y, Manas E, Ho DM, Deecher DC, Trybulski EJ",,598114.0,DTCT0023180,3098197,DTCC00137288,1115976,36091,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6696,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19713106.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells,,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2009.0,19.0,19.0,"Mahaney PE, Kim CY, Coghlan RD, Cohn ST, Heffernan GD, Huselton CA, Terefenko EA, Vu AT, Zhang P, Burroughs KD, Cosmi SA, Bray JA, Johnston GH, Deecher DC, Trybulski EJ",,592526.0,DTCT0023180,3046006,DTCC00137288,1111217,35959,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6697,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]norepinephrine uptake at human NET expressed in MDCK-Net6 cells by scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009.0,52.0,18.0,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583225.0,DTCT0023180,2901994,DTCC00137288,1115594,35305,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6698,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19722525.0,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]nisoxetine binding to human NET expressed in MDCK-Net6 cells by plate scintillation counting,,"1- or 3-(3-Amino-2-hydroxy-1-phenyl propyl)-1,3-dihydro-2H-benzimidazol-2-ones: potent, selective, and orally efficacious norepinephrine reuptake inhibitors.",J. Med. Chem.,2009.0,52.0,18.0,"Zhang P, Terefenko EA, Bray J, Deecher D, Fensome A, Harrison J, Kim C, Koury E, Mark L, McComas CC, Mugford CA, Trybulski EJ, Vu AT, Whiteside GT, Mahaney PE",,583226.0,DTCT0023180,2901995,DTCC00137288,1115594,35305,2.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6699,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19791802.0,KI,=,5.11,NM,,,,,,,,,,,,,,Inhibition of [3H]norepinephrine reuptake at norepinephrine transporter,,"Synthesis of 1,1-[1-naphthyloxy-2-thiophenyl]-2-methylaminomethylcyclopropanes and their evaluation as inhibitors of serotonin, norepinephrine, and dopamine transporters.",J. Med. Chem.,2009.0,52.0,19.0,"White JD, Juniku R, Huang K, Yang J, Wong DT",,582829.0,DTCT0023180,2903522,DTCC00137288,1104182,35322,5.11,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6700,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,19836247.0,KI,=,0.6,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake at NET,,"Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indoles.",Bioorg. Med. Chem.,2009.0,17.0,22.0,"Heffernan GD, Coghlan RD, Manas ES, McDevitt RE, Li Y, Mahaney PE, Robichaud AJ, Huselton C, Alfinito P, Bray JA, Cosmi SA, Johnston GH, Kenney T, Koury E, Winneker RC, Deecher DC, Trybulski EJ",,603447.0,DTCT0023180,3155572,DTCC00137288,1116118,36729,0.6,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6701,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864.0,IC50,=,3.3,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010.0,53.0,5.0,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611008.0,DTCT0023180,3217339,DTCC00137288,1116226,37100,3.3,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6702,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20131864.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of norepinephrine uptake at human NET expressed in MDCK-Net6 cells,,1-(Indolin-1-yl)-1-phenyl-3-propan-2-olamines as potent and selective norepinephrine reuptake inhibitors.,J. Med. Chem.,2010.0,53.0,5.0,"Vu AT, Cohn ST, Zhang P, Kim CY, Mahaney PE, Bray JA, Johnston GH, Koury EJ, Cosmi SA, Deecher DC, Smith VA, Harrison JE, Leventhal L, Whiteside GT, Kennedy JD, Trybulski EJ",,611007.0,DTCT0023180,3217338,DTCC00137288,1116226,37100,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6703,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20378347.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET transfected in MDCK-Net6 cells,,Heterocyclic cycloalkanol ethylamines as norepinephrine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,2010.0,20.0,9.0,"Sabatucci JP, Mahaney PE, Leiter J, Johnston G, Burroughs K, Cosmi S, Zhang Y, Ho D, Deecher DC, Trybulski E",,632360.0,DTCT0023180,3324054,DTCC00137288,1116418,38843,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6704,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211.0,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010.0,53.0,11.0,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634327.0,DTCT0023180,3342618,DTCC00137288,1099249,39069,2.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6705,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20462211.0,KI,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET-mediated norepinephrine uptake in MDCK-Net6 cells,,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,2010.0,53.0,11.0,"O'Neill DJ, Adedoyin A, Alfinito PD, Bray JA, Cosmi S, Deecher DC, Fensome A, Harrison J, Leventhal L, Mann C, McComas CC, Sullivan NR, Spangler TB, Uveges AJ, Trybulski EJ, Whiteside GT, Zhang P",,634326.0,DTCT0023180,3342617,DTCC00137288,1099249,39069,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6706,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,20945906.0,KD,=,0.83,NM,,,,,,,,,,,,,,Inhibition of human NET,,Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain.,J. Med. Chem.,2010.0,53.0,21.0,"Altenbach RJ, Black LA, Strakhova MI, Manelli AM, Carr TL, Marsh KC, Wetter JM, Wensink EJ, Hsieh GC, Honore P, Garrison TR, Brioni JD, Cowart MD",,685427.0,DTCT0023180,3584355,DTCC00137288,1116771,41905,0.83,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6707,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Inhibition of human NET expressed in MDCK-Net6 cells assessed as inhibition of norepinephrine uptake,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011.0,54.0,19.0,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769841.0,DTCT0023180,6093895,DTCC00137288,1123629,45987,3.4,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6708,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,21916421.0,KI,=,2.1,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in MDCK-Net6 cells,,"Discovery of Novel Selective Norepinephrine Inhibitors: 1-(2-Morpholin-2-ylethyl)-3-aryl-1,3-dihydro-2,1,3-benzothiadiazole 2,2-Dioxides (WYE-114152).",J. Med. Chem.,2011.0,54.0,19.0,"O'Neill DJ, Adedoyin A, Bray JA, Deecher DC, Fensome A, Goldberg JA, Harrison J, Leventhal L, Mann C, Mark L, Nogle L, Sullivan NR, Spangler TB, Terefenko EA, Trybulski EJ, Uveges AJ, Vu A, Whiteside GT, Zhang P",,769842.0,DTCT0023180,6093882,DTCC00137288,1123629,45987,2.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6709,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23403082.0,IC50,=,0.93,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965300.0,DTCT0023180,12469488,DTCC00137288,1127139,54795,0.93,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6710,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23403082.0,INHIBITION,=,49.0,%,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells at 10 uM after 3 hrs relative to control,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965628.0,DTCT0023180,12469556,DTCC00137288,1127139,54795,49.0,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6711,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,23403082.0,KI,=,0.92,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]RTI55 from human recombinant norepinephrine transporter expressed in MDCK cells after 3 hrs,,Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.,Bioorg. Med. Chem. Lett.,2013.0,23.0,6.0,"Germain AR, Carmody LC, Nag PP, Morgan B, Verplank L, Fernandez C, Donckele E, Feng Y, Perez JR, Dandapani S, Palmer M, Lander ES, Gupta PB, Schreiber SL, Munoz B",,965300.0,DTCT0023180,12469422,DTCC00137288,1127139,54795,0.92,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6712,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24012181.0,IC50,=,1.5,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]Nisoxetine from human recombinant NET over-expressed in dog MDCK cells,,"Synthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors.",Bioorg. Med. Chem. Lett.,2013.0,23.0,20.0,"Park JE, Song C, Choi K, Sim T, Moon B, Roh EJ",,983926.0,DTCT0023180,12598060,DTCC00137288,1127328,55968,1.5,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6713,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,=,1.1,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984039,DTCC00137288,1127527,56928,1.1,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6714,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,24365159.0,KI,=,1.15,NM,,,,,,,,,,,,,,Displacement of [3H]Nisoxetine from norepinephrine transporter (unknown origin),,"The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.",Bioorg. Med. Chem. Lett.,2014.0,24.0,2.0,"Rajagopalan R, Bandyopadhyaya A, Rajagopalan DR, Rajagopalan P",,1283696.0,DTCT0023180,12984005,DTCC00137288,1127527,56928,1.15,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6715,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7352886,DTCC00137288,1124448,46191,,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6716,CHEMBL72,P23975,DESIPRAMINE,HCYAFALTSJYZDH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7352887,DTCC00137288,1124448,46191,,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31,CNCCCN1c2ccccc2CCc2ccccc21
6721,CHEMBL726,P23975,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,1962.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7326934,DTCC00162562,1734056,46191,1962.0,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
6722,CHEMBL726,P23975,FLUPHENAZINE,PLDUPXSUYLZYBN-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,1946.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7326935,DTCC00162562,1734056,46191,1946.0,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
6754,CHEMBL773,P23975,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7304002,DTCC00168448,1544900,46191,,C(C(=O)O)N,NCC(=O)O
6755,CHEMBL773,P23975,GLYCINE,DHMQDGOQFOQNFH-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7304003,DTCC00168448,1544900,46191,,C(C(=O)O)N,NCC(=O)O
6812,CHEMBL828,P23975,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,=,461.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7389433,DTCC00179549,1734060,46191,461.0,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,c1ccc2c(c1)Nc1ccccc1S2
6813,CHEMBL828,P23975,PHENOTHIAZINE,WJFKNYWRSNBZNX-UHFFFAOYSA-N,0,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,=,457.0,NM,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),,DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7389434,DTCC00179549,1734060,46191,457.0,C1=CC=C2C(=C1)NC3=CC=CC=C3S2,c1ccc2c(c1)Nc1ccccc1S2
6836,CHEMBL85,P23975,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7464362,DTCC00138594,1383782,46191,,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
6837,CHEMBL85,P23975,RISPERIDONE,RAPZEAPATHNIPO-UHFFFAOYSA-N,4,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7464363,DTCC00138594,1383782,46191,,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
6851,CHEMBL86304,P23975,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,IC50,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7407118,DTCC00246764,833162,46191,,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1
6852,CHEMBL86304,P23975,MOCLOBEMIDE,YHXISWVBGDMDLQ-UHFFFAOYSA-N,3,NOREPINEPHRINE TRANSPORTER,SLC6A2,Transporter,,,,KI,,,,,,,,,,,,,,,,MDCK,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),DrugMatrix in vitro pharmacology data,,,,,"Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program",,774705.0,DTCT0023180,7407119,DTCC00246764,833162,46191,,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,O=C(NCCN1CCOCC1)c1ccc(Cl)cc1
